Respirology

Previous issue Volume 24 Supplement Issue s2
November 2019
Next issue
Special Issue: 24th Congress of the Asian Pacific Society of Respirology, Hanoi, Vietnam, 14–17 November 2019
Index Submit
an article
About
Respirology
Read this
issue's articles
Clinical Respiratory Medicine
4THE INFLUENCE OF THE HISTORY OF MALIGNANT TUMOR ON THE CLINICAL FEATURES OF SARCOIDOSIS
4FACTORS AFFECTING SUCCESS OF CHEMICAL PLEURODESIS IN MALIGNANT PLEURAL EFFUSION IN CHINESE PATIENTS IN HONG KONG
4FLUCLOXACILLIN INDUCED ACUTE EOSINOPHILIC PNEUMONIA
5SOUND CHARACTERISTICS OF RUMBLING RHONCHI IN ASTHMATICS
6POSTURAL CHANGES AND LATERALITY OF LUNG SOUND INTENSITY IN HEALTHY SUBJECTS
6COMPARATIVE ANALYSIS OF CLINICAL FEATURES IN PATIENTS WITH SARCOIDOSIS WHO HAVE DISCORDANT LEVELS OF SERUM CATHEPSIN S AND ACE
6FEVER, HEPATIC DYSFUNCTION AND RESPIRATORY FAILURE BY INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) ISTILLATION; BCGITIS
7RESPIRATORY CARE IN CHILDREN WITH CEREBRAL PALSY
7DEVELOPMENT OF THE NEW ZEALAND BRONCHIECTASIS REGISTRY
8AN INSTRUCTION SHEET FOR SKIN PRICK TEST(SPT) WAS FORMULATED BY MULTI-DISCIPLINARY TEAM
8DILEMMA OF CLINICIAN: MAKING CLINICAL DECISION SANS SUPPORTIVE CLINICAL FEATURES—PERSISTENT FEVER DUE TO LOFGREN SYNDROME
9PNEUMONITIS FOLLOWING DIESEL FUEL SIPHONAGE: A CASE REPORT
9CLINICAL, PARACLINICAL FEATURES AND HISTOLOGIC CAUSES OF PATIENTS WITH MALIGNANT CENTRAL AIRWAY OBSTRUCTION
9CASE STUTY INCOMPATIBILITY OF FOSFOMYCIN WITH CIPROFLOXACIN
Cell and Molecular Biology
10A NOVEL NORDIHYDROGUAIARERTIC ACID ANALOGUE, COMPOUND 3A, ALLEVIATES ACUTE LUNG INJURY BY EXHIBITING ITS ANTI-INFLAMMATORY, ANTI-OXIDATIVE AND ANTI-APOPTOSIS EFFECTS
10CHRONIC CIGARETTE SMOKE-INDUCED EMPHYSEMA AND LUNG INFLAMMATION ARE CORRELATED WITH CHANGES IN CT AND MRI THAT ARE ATTENUATED BY LOW-DOSE AZITHROMYCIN IN MICE
10BOS IS ASSOCIATED WITH INCREASED SENESCENT, PRO-INFLAMMATORY T AND NKT-LIKE LYMPHOCYTES IN THE SMALL AIRWAYS
11IS ZINC A NOVEL VASCULAR SIGNALING MESSENGER AND TARGET IN PULMONARY HYPERTENSION?
11DEVICE, FLAVOUR, AND COIL TEMPERATURE IN AN E-CIGARETTE ALL CONTRIBUTE TO VIABILITY OF PRIMARY BRONCHIAL EPITHELIAL CELLS AND EFFEROCYTOSIS OF APOPTOTIC BRONCHIAL CELLS BY MACROPHAGES
11COMPREHENSIVE METABOLOME ANALYSIS REVEALS NEW MECHANISM OF ANTI-FIBROTIC FACTOR STANNIOCALCIN-1 (STC1) WHICH MODULATE EPIGENETIC REGULATION AND OXIDATIVE STRESS
12LUNG RESIDENT MESENCHYMAL STEM CELL REGULATED PULMONARY IMFLAMMATION THROUGH THE HVEM-BTLA PATHWAY
12A CHALCONE DERIVATIVE, COMPOUND 37, EXERTS ANTI-INFLAMMATORY AND ANTI-OXIDANT EFFECTS ON LIPOPOLYSACCHARIDE-INDUCED ACUTE LUNG INJURY BY INHIBITING MAPK/NF-KB PATHWAY AND ACTIVATING NRF2/HO-1 PATHWAY
12INVESTIGATING HUMAN AND BACTERIAL READS FROM NEXT-GENERATION SEQUENCING AS PATHOGEN DETECTION IN RESPIRATORY TRACT INFECTIONS
13SMALL MOLECULE A ATTENUATES LIPOPOLYSACCHARIDES INDUCED-INOS AND INFLAMMATION IN ALI MICE MODEL
13THE EFFECTIVE MIGRATION AND ANTI-INFLAMMATORY EFFECTS OF HUMAN DERMAL-DERIVED MESENCHYMAL STEM CELLS IN ENDOTOXIN-INDUCED EXPERIMENTAL MOUSE MODEL
Clinical Allergy and Immunology
13PERSISTENT ASTHMA FROM CHILDHOOD TO ADULTHOOD PRESENTS A DIFFERENT PHENOTYPE IN ADULT ASTHMA
14CLUSTER ANALYSIS OF EXHALED NITRIC OXIDE PARAMETERS (FENO, CANO AND JAWNO) IN OUTPATIENTS VISITED RESPIRATORY, ALLERGY AND CLINICAL IMMUNOLOGY IN VINMEC TIME CITY INTERNATIONAL HOSPITAL
Environmental and Occupational Health and Epidemiology
14CHARACTERISATION OF CHILDREN HOSPITALSED WITH PNEUMONIA IN CENTRAL VIETNAM: A PROSPECTIVE STUDY
15IDENTIFICATION OF LONG NON-CODING RNA AND CIRCULAR RNA IN MICE AFTER INTRA-TRACHEAL INSTILLATION WITH FINE PARTICULATE MATTER
15PM2.5 COULD INDUCE EMT BY NLRP3 INFLAMMASOME ACTIVATION
15STAY INDOORS TO AVOID EXPOSURE TO HIGH-DENSITY FINE PARTICULATES
16ROLE OF ZC3H4 IN SILICA-INDUCED PULMONARY FIBROSIS
16ANALYSIS OF CARBON MONOXIDE EXPOSURE AND ITS EFFECT TO LUNG FUNCTION OF PARKING OFFICER IN BASEMENT MAL X PEKANBARU
16INVESTIGATION OF SILICOSIS CAUSED BY AGGLOMERATED QUARTZ STONE PROCESSING DUST
17SHORT-TERM EFFECTS OF AMBIENT AIR POLLUTANTS ON HOSPITALIZATION FOR RESPIRATORY DISEASES IN HANOI ADULTS, VIETNAM
17FRACTIONAL EXHALED NITRIC OXIDE (FENO) AND ASSOCIATED FACTORS OF WOMEN EXPOSED TO BIOMASS FUEL SMOKE: FINDINGS FROM SRI LANKA
18A DEEP LEARNING COMPUTER-ASSISTED DIAGNOSIS AIDING PROGRAM WITH CT SCAN FOR SCREENING OF ASBESTOSIS
18DIAGNOSIS OF INVASIVE PULMONARY ASPERGILLOSIS IN IMMUNOCOMPROMISED HOSTS BY NEXT GENERATION SEQUENCING
18CRB-65 SCORE IN PREDICTING OUTCOME OF PNEUMONIA IN HEMODIALYSIS PATIENTS
19PREDICTING ATYPICAL PATHOGENS IN COMMUNITY-ACQUIRED PNEUMONIA: EPIDEMIOLOGICAL STUDY OF RESPIRATORY TRACT INFECTION USING MULTIPLEX PCR ASSAYS
19CORRELATION BETWEEN RISK FACTOR OF INVASIVE CANDIDIASIS AND 1,3-β-D-GLUCAN IN SEPTIC PNEUMONIA
20PULMONARY NON-TUBERCULOUS MYCOBACTERIUM INFECTION: THE WAIKATO EXPERIENCE 2010/2017
20ANALYSIS OF STRAIN DISTRIBUTION AND CLINICAL CHARACTERISTICS OF NON-TUBERCULOUS MYCOBACTERIA ISOLATES IN SHANGHAI
20A RARE PRESENTATION OF INVASIVE PULMONARY MUCORMYCOSIS WITH CENTRAL BRONCHOPLEURAL FISTULA
21CLINICAL CHARACTERISTICS AND PROGNOSIS OF CHRONIC PULMONARY ASPERGILLOSIS IN PATIENTS WITH PREVIOUS OR ACTIVE TUBERCULOSIS
21IMPAIRED COUGH- AND SPUTUM-RELATED QUALITY OF LIFE IN PATIENTS WITH NONTUBERCULOUS MYCOBACTERIOSIS
23DEVELOPMENT AND VALIDATION OF A NOMOGRAM FOR PREDICTING STROKE-ASSOCIATED PNEUMONIA IN PATIENTS WITH ACUTE ISCHEMIC STROKE
23DIAGNOSIS OF LOWER RESPIRATORY TRACT DISEASE (LRTD) AND PNEUMONIA USING A SMARTPHONE-BASED COUGH-CENTRED ALGORITHM IN AN ADOLESCENT AND ADULT ACUTE-CARE COHORT
23HIGH EXPRESSION OF PROGRAMMED DEATH-LIGAND 1 in SURGICAL LUNG BIOPSY PROVEN GRANULOMATOUS SITE IN INFECTIOUS LESIONS in NON-TUBERCULOUS MYCOBACTERIUM LUNG DISEASE
24TIME TO EVENT ANALYSIS OF VAP IN PATIENTS UNDERGOING CARDIAC SURGERY
24SYSTEMATIC REVIEW AND META-ANALYSIS OF MORTALITY PREDICTORS IN PATIENTS WITH CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII
25A CAS STUDY POST-DROWING ASPIRATION PNEUMONIA NEED BRONCHOSCOPY THREE TIMES
26CHALLENGES IN THE DIAGNOSE AND TREATMENT OF NON-TUBERCULOSIS MYCOBACTERIA PULMONARY DISEASE (NTM-PD)
Tuberculosis
26GAPS IN TUBERCULOSIS INFECTION CONTROL FOR MEDICAL STAFF IN A TERTIARY AND GENERAL HOSPITAL IN VIETNAM
27THE TREATMENT CASCADE; THE USE OF PREVENTATIVE PHARMACOTHERAPY FOR LATENT TUBERCULOSIS INFECTION FOLLOWING HIGH RISK NOSOCOMIAL EXPOSURE TO MULTI-DRUG RESISTANT TUBERCULOSIS
27SECONDARY SPONTANEOUS PNEUMOTHORAX SECONDARY TO TUBERCULOSIS WITH KLEBSIELLA AND PSEUDOMONAS CO-INFECTION: A CASE REPORT
28SECONDARY SPONTANEOUS PNEUMOTHORAX SECONDARY TO TUBERCULOSIS WITH KLEBSIELLA AND PSEUDOMONAS CO-INFECTION: A CASE REPORT MARTIN KRISTOFFER ELISES OGBAC
28DISSEMINATED TUBERCULOSIS IN A 6-YEAR-OLD MALE: A CASE REPORT
28LOCAL PATIENTS' PERCEPTIONS OF "DIRECTLY OBSERVED THERAPY" (DOT) IN TB MANAGEMENT
29SMEAR POSITIVE PULMONARY TUBERCULOSIS UNDETECTED AT THE DISTRICT HOSPITALS IN SOUTHERN VIETNAM
29CONGENITAL DISSEMINATED TUBERCULOSIS: A DIAGNOSTIC DILEMMA
29SUCCESSFUL HIGH-DOSE STEROID RE-ADDITION TO ANTI-TUBERCULOUS THERAPY IN A PATIENT WITH REFRACTORY TUBERCULOUS MENINGITIS
29TREATMENT SUCCESS OF DRUG RESISTANT TUBERCULOSIS IN HUMAN IMMUNODEFICIENCY VIRUS COINFECTED PATIENT AND RELATED FACTORS
30THE ROLE OF INDUCED SPUTUM IN THE DIAGNOSIS OF PULMONARY TUBERCULOSIS AND COMPARISON WITH BRONCHOSCOPY
30COMMUNITY ACTIVE CASE FINDING FOR PULMONARY TUBERCULOSIS
30THE ROLE OF DIGITAL CHEST RADIOGRAPHY AND GENEXPERT MTB/RIF IN COMMUNITY-WIDE ACTIVE CASE FINDING FOR TUBERCULOSIS
31PREVIOUSLY TREATED DRUG-RESISTANT TUBERCULOSIS (DR-TB) HAVE LOWER BMI THAN PRIMARY DR-TB
31PHARMACOKINETICS/PHARMACODYNAMICS FEATURES OF RIFAMPICIN IN VIETNAMESE PULMONARY TUBERCULOSIS PATIENTS
31DIAGNOSTIC YIELD WITH GenXpert MTB/RIF IN PATIENTS IN PATIENTS WITH PRODUCTIVE VS. NON-PRODUCTIVE COUGH
32CLINICAL CHARACTERISTICS AND TREATMENT OUTCOME OF MULTIDRUG-RESISTANT TUBERCULOSIS IN A TERTIARY CENTRE IN MALAYSIA: A TWO-YEAR EXPERIENCE
33ANALYSIS OF PATIENT CHARACTERISTICS AMONG MYCOBACTERIUM TUBERCULOSIS TREATMENT COSTS
34INCIDENCE OF FLUOROQUINOLONES RESISTANCE IN MDR-TB PATIENTS
34DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH MDR-TB IN VIETNAM
35PREVALENCE OF LATENT TUBERCULOSIS AMONG HOUSEHOLD CONTACTS OF PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS IN VIETNAM
35THE EFFECTIVENESS OF A PUBLIC HEALTH INTERVENTION UPON THE SCREENING FOR LATENT TUBERCULOSIS INFECTION AMONG HOUSEHOLD CONTACTS IN CENTRAL VIETNAM
COPD
36EFFECT OF A COPD DISCHARGE BUNDLE ON READMISSION OUTCOMES: A PRELIMINARY COHORT STUDY IN A PRIVATE TERTIARY HOSPITAL IN THE PHILIPPINES
36ABNORMAL DNA METHYLATION AND EXPRESSION OF NRF2 IN COPD
36LONGITUDINAL CHANGE IN AIR TRAPPING AND ASSOCIATED CHANGE IN LUNG FUNCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
38COMPARISON AND CONSTRUCTION OF THE PRIMARY SCREENING AND DISCRIMINATE MODELS FOR COPD
39CARDIOVASCULAR CO-MORBIDITIES OF COPD AND PRISM IN NON-SMOKING POPULATION
39THE RELEVANCE BETWEEN SMALL AIRWAY DISEASE AND LUNG BLOOD PERFUSION IN COPD: A PRELIMINARY STUDY
40ARE ALL FIXED-DOSE LABA/LAMA COMBINATIONS CREATED EQUAL?
40THE RISK ANALYSIS OF ANXIETY AND DEPRESSION IN COPD PATIENTS DURING CONTINUOUS MEDICATION AND STEADY STATE
40HBO1 ATTENUATE LUNG APOPTOSIS IN CIGARETTE SMOKE EXTRACT-INDUCED EMPHYSEMA MODEL VIA THE WNT SIGNALLING PATHWAY
41INITIAL EVALUATION ON TREATMENT OF COPD WITH ADIPOSE-DERIVED STEM CELLS
41IL-33 AND TSLP RECEPTOR EXPRESSION ON AIRWAY DENDRITIC CELLS IN STABLE, NON-ATOPIC, EOSINOPHILIC COPD
41RELATIONSHIP BETWEEN NUTRITIONAL STATUS AND LUNG FUNCTION IN HOSPITALIZED ELDERLY PATIENTS WITH ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BASED ON GERIATRIC NUTRITIONAL RISK INDEX
42ANALYSIS OF RISK FACTORS FOR SHORT-TERM READMISSION AFTER ACUTE EXACERBATION OF COPD: A REGRESSION ANALYSIS BASED ON DATABASE
42THE RADIOGRAPHIC BRONCHIECTASIS IN PATIENTS WITH COPD-OSA OVERLAP SYNDROME
43IMPACT OF ABNORMAL BLOOD GLUCOSE AND STRESS HYPERGLYCAEMIA RATIO ON SHORT-TERM OUTCOMES IN ACUTE EXACERBATION OF COPD
43INITIAL RESULTS OF AUTOLOGOUS BONE MARROW DERIVED STEM CELL THERAPY FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN RESPIRATORY CENTER, BACH MAI HOSPITAL
43FACTORS ASSOCIATED WITH PHYSICAL ACTIVITY IN PATIENTS WITH COPD: MULTICENTER OBSERVATIONAL STUDY
44AIR POLLUTION, HOMOCYSTEINE AND GLOBAL DNA METHYLATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A POPULATION BASED STUDY FROM INDIA
44COPD Exacerbation according to Chronic Bronchitis and Body Mass Index: Difference between KOCOSS and COPDGene study
45A CORRELATION ANALYSIS: BETWEEN NEUTROPHIL COUNT, LYMPHOCYTE COUNT, NEUTROPHIL TO LYMPHOCYTE RATIO, EOSINOPHIL COUNT, HAEMOGLOBIN CONCENTRATION AND SEVERITY OF AECOPD
45THE CLINICAL SIGNIFICANCE OF RED CELL DISTRIBUTION WIDTH, PLATELET COUNT, PRO-BNP AND FIBRINOGEN IN THE DIAGNOSIS OF PATIENTS WITH COPD COMPLICATED WITH PULMONARY HYPERTENSION
45INITIAL RESULTS OF MESENCHYMAL STEM CELL AND PLATELET RICH PLASMA IN TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AT VIETNAM
46STUDY OF THE EFFECT OF TREATMENT OF H-PYLORI INFECTION ON THE PROGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
46EVALUATION OF ASTHMA CHARACTERISTICS IN SEVERE AND EXTREMELY SEVERE COPD
47EFFECTS OF HUMAN UMBILICAL CORD-DERIVED MESENCHYMAL STEM CELLS ON CIGARETTE SMOKE-INDUCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE ANIMAL MODEL
47RACIAL DIFFERENCES IN COMORBIDITY PROFILES AMONG COPD PATIENTS WITH SMOKING HISTORY: COMPARISON DATA FROM THE KOCOSS AND COPDGENE STUDIES
48EFFECT OF LONG-TERM AZITHROMYCIN THERAPY IN COPD PATIENTS WITH OR WITHOUT BRONCHIECTASIS
48COPD AND ASTHMA-COPD OVERLAP: DIFFERENCES IN CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES
48PATIENTS' PERSPECTIVE ON CHOICE OF HEALTHCARE FACILITY FOR THE MANAGEMENT OF COPD
49STUDY OF THE DECAF SCORE TO PREDICT THE PROGNOSIS OF MORTALITY FOR ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN HUE CENTRAL HOSPITAL
Lung Cancer
49REAL WORLD STUDY ON AFATINIB IN HONG KONG
50PROGNOSTIC IMPLICATION OF DRIVER MUTATION ON RESECTED STAGE I ADENOCARCINOMA OF LUNG
50ANALYSIS OF IMMUNE RELATED ADVERSE EVENTS IN NSCLC PATIENTS RECEIVING DURVALUMAB AFTER CHEMORADIOTHERAPY IN THE REAL-WORLD CLINICAL SETTING
50OUTCOMES OF CARBON ION RADIOTHERAPY COMPARED WITH SUBLOBAR RESECTION IN GROUND GLASS OPACITY-DOMINANT EARLY-STAGE LUNG CANCER
51ERLOTINIB 100MG VERSUS 150MG IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER HARBORING MUTATIONS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR: A MULTICENTER OPEN-LABEL, RANDOMIZED PHASE 2 TRIAL
51SURVIVAL OUTCOMES OF PATIENTS WITH WEDGE RESECTION AND SEGMENTECTOMY IN STAGE IA NSCLC AND ITS MAJOR SUBTYPES
51ROLE OF SURGERY IN PATIENTS WITH EARLY STAGE SMALL-CELL LUNG CANCER
52DIAGNOSTIC AND PROGNOSTIC IMPACT OF SERUM PROCALCITONIN IN NON-SMALL CELL LUNG CANCER
52THE RISK OF SECOND PRIMARY MALIGNANCIES IN PATIENTS WITH LUNG NEUROENDOCRINE TUMORS: A NESTED CASE-CONTROL STUDY BASED ON SEER DATABASE
53CHARACTERISTICS OF PULMONARY NODULES DIAGNOSED WITH PRIMARY LUNG CANCER FOLLOWING SURGERY WITHOUT PRIOR TRANSBRONCHIAL LUNG BIOPSY
53EXAMINATION OF THE FACTORS THAT DETERMINE DURVALUMAB ADMINISTRAION IN PATIENTS WITH LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER
54SILICA LEVEL IN BRONCHOALVEOLAR LAVAGE OF LUNG CANCER PATIENT
54DIAGNOSTIC VALUE OF EGFR MUTATION TEST FROM PLASMA (CTDNA) COMPARED WITH TISSUE SAMPLE ON NON-SMALL CELL LUNG CANCER
54PD-L1 IMMUNOHISTOCHEMISTRY FOR LUNG CANCER CYTOLOGY CELL BLOCKS OBTAINED BY TRANSBRONCHIAL FINE NEEDLE ASPIRATION CYTOLOGY
55CORRELATION BETWEEN TOTAL LYMPHOCYTE COUNT AND 1,3 B-D-GLUCAN LEVELS FOR RISK OF INVASIVE CANDIDIASIS IN LUNG CANCER PATIENTS
55CELL-FREE DNA AS PROGNOSTIC FACTOR IN LUNG ADENOCARCINOMA
55EFFICACY OF GEFITINIB AND ERLOTINIB IN INDONESIAN PATIENTS WITH LUNG ADENOCARCINOMA WITH ACTIVATING EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATIONS
56DIAGNOSTIC TEST OF CANCER RATIO EXAMINATION OF MALIGNANT PLEURAL EFFUSION PATIENTS AT PERSAHABATAN HOSPITAL JAKARTA
56DIAGNOSTIC ACCURACY OF L1 HOUNSFIELD UNIT METHOD COMPARED TO QCT IN DETECTING OSTEOPOROSIS IN A LUNG CANCER SCREENING COHORT
56International Lung Screen Trial – results from Queensland and Western Australia
57EGFR GENE MUTATION IN PULMONARY ADENOCARCINOMA
57EVALUATE THE NATURAL KILLER CELL ACTIVITY IN PATIENTS WITH ADVANCED STAGE NON SMALL CELL LUNG CANCER
57RESULT OF THORACOSCOPIC TALC PLEURODESIS TREATED MALIGNANT PLEURAL EFFUSIONS IN 103 HOSPITAL FROM 2013 TO 2018
58A CASE OF DERMATOMYOSITIS WITH MISSED LUNG CANCER AND CONCURRENCE OF PULMONARY TUBERCULOSIS
58PREVALENCE OF LATENT TUBERCULOSIS INFECTION AMONG PATIENTS WITH LUNG CANCER
58LONG TERM RESULTS OF VATS LOBECTOMY VERSUS OPENED LOBECTOMY FOR EARLY STAGE NON SMALL CELL LUNG CANCER
58LONG NON-CODING RNA GROWTH ARREST SPECIFIC-5: A POTENTIAL BIOMARKER FOR DIAGNOSIS OF SEVERE ASTHMA
59INTERNATIONAL SEVERE ASTHMA REGISTRY (ISAR): PROTOCOL FOR A GLOBAL REGISTRY
59IMPROVEMENT OF CONTROLLED ASTHMA IN PATIENTS WITH ASTHMA DURING GINA IMPLEMENTATION: A 5-YEAR OBSERVATIONAL FOLLOW-UP STUDY
59INVESTIGATION OF FACTORS THAT RELATED TO THE VARIABILITY OF FRACTIONAL EXHALED NITRIC OXIDE
60A NOVEL MOUSE MODEL OF EOSINOPHILIC BRONCHITIS WAS ESTABLISHED BY NON-INVASIVE AND INVASIVE AIRWAY REACTIVITY DETECTION METHODS
60SCREENING FOR AIRWAY HYPERRESPONSIVENESS-ASSOCIATED DIFFERENTIAL PROTEINS BY PROTEOMICS
60FUNCTIONAL SMALL AIRWAYS DISEASE DERIVED FROM PARAMETRIC RESPONSE MAPPING IN ASTHMA
61FRACTIONAL EXHALED NITRIC OXIDE (FENO) ANALYSIS IN THE MANAGEMENT OF COUGH- VARIANT ASTHMA
61STUDY OF ALVEOLAR CONCENTRATION OF NITRIC OXIDE (CANO) IN DIAGNOSIS AND TREATMENT OF CHILDREN WITH ASTHMA
61EFFECT OF MYCOVIRUSES AFPV ON BIOLOGICAL CHARACTERISTICS OF ASPERGILLUS FLAVUS
62DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH SEVERE ASTHMA IN JAPAN AND Republic of Korea
63IS INHALED STEROID-FORMOTEROL ESSENTIAL FOR SUCCESS IN ASTHMA ACTION PLANS?
Respiratory Neurobiology and Sleep
63MIRNA-335-5P MEDIATES INTERMITTENT HYPOXIA-INDUCED INJURY IN HUVEC CELLS BY TARGETING BECLIN1
63HOW VASCULAR-RELATED FACTORS BECOME "THE FLYOVER" BETWEEN OSA AND DEPRESSION
64HOW TO DIAGNOSE OBSTRUCTIVE SLEEP APNEA IN PATIENTS UNDERGOING CARDIOVASCULAR SURGERY
64MULTI-CENTER STUDY TO ADAPT STOP-BANG QUESTIONNAIRE TO VIETNAMESE POPULATION
65MIF MAY BE A NOVAL FACTOR ASSOCIATED WITH OSAHS INDUCED LIVER INJURY
65ASSESSMENT OF THE SEVERITY OF OBSTRUCTIVE SLEEP APNEA USING STOP AND EPWORTH QUESTIONNAIRES
66ANATOMICAL STRUCTURE AND FUNCTIONAL CHARACTERISTICS OF UPPER AIRWAY IN PATIENTS WITH OSA
66ALTERED EXOSOME MICRORNA PROFILE IN BRONCHOALVEOLAR LAVAGE IS CORRELATED TO SERUM METABOLITES DYSREGULATION IN PATIENTS WITH ACINETOBACTER BAUMANNII VENTILATOR-ASSOCIATED PNEUMONIA
66NOVEL INTERACTIVE PATIENT CENTERED CARE-THE INTRODUCE OF SHARED DECISION MAKING IMPACT ON EARLY TRACHEOSTOMY IN PROLONGED INTUBATED CRITICAL PATIENT
67VASOPRESSOR DISCONTINUATION ORDER IN THE RECOVERY PHASE OF SEPTIC SHOCK: A META-ANALYSIS AND SYSTEMATIC REVIEW
67THE RELATIONSHIP BETWEEN HIGH-RESOLUTION COMPUTED TOMOGRAPHY FINDINGS AND HISTOPATHOLOGICAL FEATURES IN AUTOPSY CASES WITH ACUTE RESPIRATORY DISTRESS SYNDROME
67REMOTE ISCHEMIC PRECONDITIONING's PROTECTIVE EFFECT ON LUNG INJURY AFTER CARDIOPULMONARY BYPASS: A META-ANALYSIS
68THE PROGNOSTIC ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN SEPSIS AND RELATED MORTALITY
68EFFECT OF TITRATED POSITIVE END EXPIRATORY PRESSURE (PEEP) ON THE QUASI STATIC PRESSURE–VOLUME (P-V) LOOP VS LOW PEEP IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME
68PHOTODYNAMIC THERAPY FOR PERIPHERAL-TYPE LUNG CANCER IN A MULTI-CENTER CLINICAL TRIAL
69EFFICACY AND SAFETY OF CRYO TRANSBRONCHIAL LUNG BIOPSY VS FORCEPS LUNG BIOPSY IN INTERSTITIAL LUNG DISEASES AND LUNG CANCER
69EFFICACY OF GENE XPERT MTB / RIF ASSAY AND AFB CULTURE IN DIAGNOSIS OF MYCOBACTERIUM TUBERCULOSIS COMPLEX ON EBUS TBNA
69ENDOBRONCHIAL ULTRASOUND BRONCHOSCOPY - INITIAL EXPERIENCE IN VIETNAM
70USEFULNESS OF JACKSON MASK VENTILATION DURING BRONCHOSCOPY IN PATIENTS PRESENTING WITH ACUTE RESPIRATORY FAILURE
70INTRAPLEURAL FOREIGN BODY RETRIEVAL WITH SEMI RIGID THORACOSCOPY UNDER SINGLE LUNG VENTILATION
71DIAGNOSTIC UTILITY OF BRONCHOSCOPY FOR PERIPHERAL PULMONARY LESIONS WITH IDIOPATHIC PULMONARY FIBROSIS
71EFFICACY OF INTRABRONCHIAL VORICONAZOLE INSTILLATION FOR INOPERABLE PULMONARY ASPERGILLOMA: A RANDOMIZEDCONTROLLED TRIAL
72A SHORT-TERM STUDY OF THE EFFICACY AND SAFETY OF GIANT EMPHYSEMATOUS BULLA VOLUME REDUCTION VIA MEDICAL THORACOSCOPE
73IMPACT OF FROZEN SECTION EVALUATION OF PLEUROSCOPIC BIOPSY IN MANAGEMENT OF PLEURAL EFFUSION
73THE INITIAL RESULT OF BRONCHOSCOPIC LUNG VOLUME REDUCTION BY ONE-WAY VALVE IN TREATMENT OF COPD PATIENTS WITH SEVERE EMPHYSEMA IN VIETNAM
73COMPUTED TOMOGRAPHY-GUIDED PERCUTANEOUS TRANSTHORACIC NEEDLE BIOPSY FOR SOLITARY PULMONARY NODULES IN DIAMETER LESS THAN 30 MM
74A FUNDAMENTAL STUDY OF RADIAL ENDOBRONCHIAL ULTRASOUND IMAGES TO CLARIFY THE EXISTENCE OF GROUND-GLASS NODULES
74PREDICTORS OF ‘UNLIKELY BACTERIAL PNEUMONIA' AND ‘ADVERSE OUTCOME' IN VIETNAMESE CHILDREN ADMITTED WITH PNEUMONIA
75ANTIBIOTIC USE IN CHILDREN HOSPITALISED WITH PNEUMONIA IN CENTRAL VIETNAM: A PROSPECTIVE STUDY
75PAROXYSMAL COUGH AS A PRESENTING FEATURE OF AN INFANT WITH PIG BRONCHUS: A CASE REPORT
75COMMUNITY ACQUIRED PNEUMONIA (CAP) IN CHILDREN: VALUE DRIVEN CARE INITIATIVE, MINISTRY OF HEALTH, SINGAPORE
76CLINICAL ASSESSMENT ON THE SEVERITY OF THE LUNG DISEASE IN YOUNG INDIVIDUALS WITH CYSTIC FIBROSIS IN JAPAN
76SWEAT CHLORIDE TESTING BY PILOCARPINE IONTOPHORESIS FOR THE DIAGNOSIS OF CYSTIC FIBROSIS : AN OBSERVATIONAL STUDY IN BANGLADESH SCENARIO
77ASTHMA SYMPTOMS, FRACTIONAL EXHALED NITRIC OXIDE LEVELS, EOSINOPHIL COUNT AND SPIROMETRY IN A COHORT OF 7– 14 YEAR OLD ASTHMATICS IN SRI LANKA: A PRELIMINARY REPORT
77NATIONAL CONSENSUS ON NEBULIZATION THERAPY IN CHILDREN WITH ASTHMA EXACERBATIONS
Respiratory Structure and Function
78RELATIONSHIP BETWEEN AIRWAY TREE TO LUNG VOLUME RATIO AND SMALL AIRWAY DISEASE IN COPD
78RARE PRESENTATION OF PULMONARY VARIX WITH PULMONARY AGENESIS
79THE ACCURACY OF IMPULSE OSILLOMETRY SYSTEM (IOS) AS A SURROGATE TEST IN DETERMINING VENTILATORY PATTERNS AMONG FILIPINO ADULTS SEEN AT MANILA DOCTORS HOSPITAL
79BETA-BLOCKER: A CAUSE OF COUGH SYNCOPE WITH AN IMPORTANT PATHOPHYSIOLOGY
80DUAL BLOCKADE OF OREXIN RECEPTORS DOES NOT AFFECT VENTILATION IN MICE
80WEIGHT LOSS IMPROVED RESPIRATORY FUNCTION AND RESPIRATORY SYSTEM IMPEDANCE IN OBESE SUBJECTS
Pulmonary Circulation
80ADENO-ASSOCIATED VIRAL-MEDIATED DEPLETION OF CYR61 AGGRAVATES THE PROGRESSION OF PULMONARY ARTERIAL HYPERTENSION VIA INHIBITING NITRIC OXIDE PRODUCTION
81REDUCTION OF ANTIOXIDANT ACTIVITY IN RATS OF EMPHYSEMA WITH PULMONARY HYPERTENSION INDUCED BY SU5416/HYPOXIA: POTENTIAL ROLES OF VASCULAR ENDOTHELIAL GROWTH FACTOR
81THE PROGNOSTIC ROLE OF RED CELL DISTRIBUTION WIDTH IN VENOUS THROMBOEMBOLISM AND RELATED MORTALITY: A META-ANALYSIS STUDY
Interstitial Lung Disease
81CLINICAL FEATURES IN RECURRENCE OF ANTI-MDA5 AUTOANTIBODIES POSITIVE DERMATOMYOSITIS
82THE DELETION OF FAM13A EXACERBATES PULMONARY FIBROSIS BY ACTIVATING BETA-CATENIN MEDIATED EPITHELIAL TO MESENCHYMAL TRANSITION
82QUANTITATIVE ANALYSIS OF CHEST COMPUTED TOMOGRAPHY IN IDIOPATHIC PULMONARY FIBROSIS USING A NOVEL ARTIFICIAL INTELLIGENCE-BASED TECHNOLOGY
82CLINICAL SIGNIFICANCE OF PLEUROPARENCHYMAL FIBROELASTOSIS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
83BIOMARKERS OF DISEASE PROGRESSION IN ASIAN SUBJECTS WITH IDIOPATHIC PULMONARY FIBROSIS TREATED WITH NINTEDANIB: SUBGROUP ANALYSIS OF THE INMARK TRIAL
83NINTEDANIB PLUS SILDENAFIL VERSUS NINTEDANIB ALONE IN ASIAN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND SEVERELY IMPAIRED GAS EXCHANGE
84CASES PULMONARY ALVEOLAR MICROLITHIASIS IN RESPIRATORY CENTER: BACH MAI HOSPITAL
85CHARACTERISTICS OF MESOTHELIAL CELLS IN FIBROTIC LESIONS OF IDIOPATHIC PULMONARY FIBROSIS
85OCCURRENCE OF OBSTRUCTIVE SLEEP APNEA IN PATIENTS OF INTERSTITIAL LUNG DISEASE
85A NATIONWIDE POST-MARKETING STUDY INVESTIGATING SAETY AND EFFICACY OF PIRFENIDONE IN KOREAN PATIENTS WITH ADVANCED IDIOPATHIC PULMONARY FIBROSIS
86MIPAF STUDY: MALAYSIAN OBSERVATIONAL STUDY TO DESCRIBE IDIOPATHIC PULMONARY FIBROSIS (IPF) BASELINE PRESENTATION AND OUTCOME WITH ANTI FIBROTIC
87THE INBUILD TRIAL OF NINTEDANIB IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES: SUBGROUP OF ASIAN PATIENTS
88HIGH-RESOLUTION COMPUTED TOMOGRAPHIC FINDINGS IN PATIENTS WITH AMIODARONE-INDUCED LUNG INJURY
89NICEFIT STUDY 1 YEAR FOLLOW UP RESULT
89THE PSYCHOLOGICAL DISTRESS THAT IDIOPATHIC PULMONARY FIBROSIS PATIENTS AND CAREGIVERS EXPERIENCE. THE INVISIBLE INJURY THAT ADDS COMPLEXITY TO MANAGEMENT AND TREATMENT
89DIAGNOSIS OF INTERSTITIAL PNEUMONIA BY TRANSBRONCHIAL CRYOBIOPSY
90THE LITERATURE ANALYSIS FOR COMPARISON OF THE QUALITY OF LIFE ASSESSMENT TOOLS FOR IDIOPATHIC PULMONARY FIBROSIS
90SERUM GALECTIN-3 COULD BE USEFUL BIOMARKER TO KNOW PROGRESSION OF PULMONARY FIBROSIS
90CLINICAL FACTORS AND OUTCOMES FOR THERAPEUTIC DELAY IN IDIOPATHIC PULMONARY FIBROSIS
Other
91A CASE REPORT OF PULMONARY ALVEOLAR PROTEINOSIS AT CHỢ RẪY HOSPITAL
91A CASE REPORT OF BRAIN ABSCESS AS COMPLICATION OF PULMONARY ARTERIO-VENOUS MALFORMATIONS AT CHỢ RẪY HOSPITAL
91TALC PLEURODESIS COMBINED WITH CONTINUOUS POSITIVE AIRWAY PRESSURE FOR REFRACTORY BENIGN PLEURAL EFFUSION DUE TO CONGESTIVE HEART FAILURE AND HEPATIC HYDROTHORAX
91SIGNET-RING CELL CARCINOMA OF UNKNOWN PRIMARY: A CASE REPORT AND REVIEW OF RELATED LITERATURE OF A RARE TYPE OF CANCER WITH A RARE PRESENTATION
92TWO OPERATED CASES OF SPONTANOUS PNEUMOTHORAX WITH MARFAN SYNDROME
92FRACTIONAL EXHALED NITRIC OXIDE IN ALLERGIC BRONCHOPULMONARY MYCOSIS
92AN UNUSUAL PRESENTATION OF PROSTATE CANCER
92ISOLATED PSAMMOMATOUS MELANOTIC SCHWANNOMA IN THE MEDIASTINUM: A RARE DIAGNOSTIC AND THERAPEUTIC PUZZLE A CASE REPORT AND REVIEW OF LITERATURE
94INTRODUCTION OF A PROJECT FOR STRENGTHENING BRONCHOSCOPY IN VIETNAM
94INTERVENTIONS FOR SMOKING CESSATION IN HEALTH SETTINGS IN LOW AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW AND META-ANALYSIS STUDY
95NATIONAL BIG DATA CENTER OF RESPIRATORY DISEASE IN CHINA
95ASKINS's TUMOUR: A RARE MALIGNANT ROUND CELL TUMOUR IN THE THORACOPULMONARY REGION IN YOUNG ADULTS-CASE REPORT AND SHORT REVIEW
96MULTI-CENTER DATA INTERGRATION AND APPLICATION BASED ON RESPIRATORY HEALTH DATA PLATFORM
97APPLYING DIGITAL TOOLS IN MANAGING CLINICAL RESEARCH: REPORT ON EXPERIENCE OF BENEFITS, ISSUES AND IMPLICATIONS ON WIDER USE
Clinical Respiratory Medicine
98PULMONARY COMPLICATIONS OF COSMETIC PROCEDURES: 2 RARE CASES AND REVIEW OF LITERATURE
98CHRONIC COUGH IS ASSOCIATED WITH DEPRESSIVE MOOD IN GENERAL POPULATION AND COPD; ANALYSIS OF DATA FROM KOREAN NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY FROM 2014 AND 2016
98ATYPICAL MANIFESTATION OF SARCOIDOSIS: ISOLATED SARCOIDOSIS OF THE TRACHEAL MUCOSA
99PLEURAL EFFUSION IN MULITPLE MYELOMA: A CASE REPORT
99GASTRIC BLEEDING AS THE FIRST CLINICAL SIGN OF THE COMBINED SARCOIDOSIS OF THE RESPIRATORY AND GASTROINTESTINAL TRACT
99A PROSPECTIVE SURVIVAL ANALYSIS OF NURSING AND HEALTHCARE ASSOCIATED PNEUMONIA
100THE CORRELATION OF END-TIDAL CO2 MEASURED BY PULSE OXI-CAPNOMETER ‘CAPNOEYE' WITH PACO2 IN PATIENTS WITH RESPIRATORY DISEASES: A RETROSPECTIVE STUDY IN A CHEST MEDICAL CENTER
101INCIDENCE OF IATROGENIC OVER-OXYGENATION IN PATIENTS ADMITTED TO HOSPITAL WITH AN ACUTE RESPIRATORY CONDITION
101THE UNFORTUNATE EVENT: AN ACUTE MASSIVE PULMONARY EMBOLISM FOLLOWING A MYOCARDIAL INFARCTION
Tuberculosis
102CLINICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH AIRFLOW OBSTRUCTION BY USING FIXED RATIO AND LOWER LIMIT OF NORMAL OF FEV1/FVC
Clinical Respiratory Medicine
102A MULTI-CENTER SURVEY ON LONG-TERM OXYGEN THERAPY WITH CHRONIC LUNG DISEASE IN Republic of Korea
102ORGANIZING PNEUMONIA SECONDARY TO DETERGENT INGESTION
103EFFECTS OF MIXTURE OF IVY LEAVES AND COPTIDIS RHIZOME IN PATIENTS WITH CHRONIC BRONCHITIS AND/OR BRONCHIECTASIS
103BENIGN METASTASIZING LEIOMYOMA OF THE LUNG: A CASE REPORT
104AIRFLOW OBSTRUCTION IN BRONCHIECTASIS: THE ASSOCIATION BETWEEN THE TYPES OF BRONCHIECTASIS AND PULMONARY FUNCTION TESTS
104CASE STUDY: 43-YEAR-OLD MALE PRESENTS WITH PERTUSSIS (WHOOPING COUGH)
104DEVELOPING A NOVEL MOBILE WEARABLE TOOL OF MEASURING REAL-TIME RESPIRATORY PATTERN AND THORACIC MOTION NON-INVASIVELY
105A DESCRIPTIVE STUDY ON CLINICAL FEATURES OF BRONCHIECTASIS IN CENTRAL SRI LANKA
105A DESCRIPTIVE STUDY ON ETIOLOGY OF BRONCHIECTASIS IN CENTRAL SRI LANKA
105EFFECT OF 24-WEEK INSPIRATORY MUSCLE TRAINING IN PATIENTS WITH MYASTHENIA GRAVIS AND ITS INFLUENCE ON QUALITY OF LIFE
105A CLINICAL AUDIT ON ANALYSIS OF PATIENTS WITH PLEURAL EFFUSION IN A TERTIARY CARE HOSPITAL IN SRI LANKA
106AN AUDIT ON ANALYSIS OF TREATMENT MODALITIES USED FOR PATIENTS WITH PLEURAL EFFUSIONS- A SINGLE CENTER EXPERIENCE
106PREDICTIVE ABILITY OF THE NUTRITIONAL RISK SCREENING (NRS2002) IN NON-INVASIVE VENTILATION OUTCOMES AMONG PATIENTS WITH ACUTE RESPIRATORY FAILURE ADMITTED IN CGHMC
106EXAMINATION OF NON-RESPIRATORY INTERNAL MEDICINE INPATIENTS WHO CONSULTED A RESPIRATORY INTERNAL MEDICINE SPECIALIST
108CORTICOSTEROID-INDUCED LEUKOCYTOSIS AND DELIRIUM
108A RARE CASE OF SPONTANEOUS HEMOTHORAX IN HEMOPHILIA A PATIENT
109THE OUTCOME OF THE USE OF HIGH FLOW NASAL OXYGEN COMPARED WITH NON-INVASIVE VENTILATION IN PATIENTS WITH ACUTE HYPOXEMIC RESPIRATORY FAILURE ADMITTED AT THE MEDICAL CITY FROM 2017 TO 2018
109PERSONALIZED INTEGRATED CARE FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A CASE REPORT
110FATTY ACIDS METABOLISM OF LEUKOCYTES IN ASTHMA-COPD OVERLAP SYNDROME
110COMPARATIVE CHARACTERISTICS OF FATTY ACID COMPOSITION OF BLOOD PLASMA AND ERYTHROCYTES IN CHRONIC RESPIRATORY DISEASES
110CYTOKINE RESPONSE AND CD14+CD282+ CELLS IN NON-SMOKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Cell and Molecular Biology
111BIOINDICATORS OF EARLY STAGE OF ALVEOLAR MACROPHAGES DAMAGE INDUCED BY EXPOSURE TO AIR MICRO-TOXICANTS
111PLASMA PLASMALOGEN LEVELS IN ASTHMA ASSOCIATED WITH OBESITY
111DECREASED EXPRESSION OF GLUCOCORTICOID RECEPTOR IN PERIPHERAL BLOOD CYTOTOXIC/PRO-INFLAMMATORY LYMPHOCYTES IN CYSTIC FIBROSIS
112TRPV4 AND FGF2 MAY BE IMPLICATED IN BRONCHIAL WALL REMODELLING UNDER MECHANICAL STRESS IN THE AIRWAYS OF ASTHMA AND COPD PATIENTS
112ALPHA-MANGOSTIN INHIBITS CD4+ T CELL AND MAST CELL ACTIVATION VIA THE Ca2+ RELEASE ACTIVATED Ca2+ CHANNEL
112GHRELIN ATTENUATES LIPOPOLYSACCHARIDE-INDUCED ACUTE LUNG INJURY INDEPENDENTLY OF VAGUS NERVE CIRCUIT
113EGFR MUTATIONS IN TISSUE SAMPLES AND RELATED FACTORS IN VIETNAMESE NON-SMALL CELL LUNG CANCER PATIENTS OVER 60 YEARS OLD
113CHARACTERISTICS OF EGFR MUTATIONS IN PLASMA SAMPLES FROM VIETNAMESE NON-SMALL CELL LUNG CANCER PATIENTS
113AIRWAY MUCIN MUC5AC PRODUCTION IS INCREASED IN PATIENTS WITH CHRONIC EOSINOPHILIC PNEUMONIA
Environmental and Occupational Health and Epidemiology
114CALCIUM-ACTIVATED CL- CHANNEL (ANO1) AND CALCIUM RELEASE-ACTIVATED CALCIUM CHANNEL (ORAI1) AS POTENTIAL THERAPEUTIC TARGETS FOR ALLERGIC RHINITIS
114THE ROLE OF VOLUNTEERS IN QUALITY PALLIATIVE CARE DELIVERY
114EPIDEMIOLOGICAL AND SOME CLINICAL CHARACTERISTICS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN NGHE AN PROVINCE
115AN INVESTIGATION ON COAL WORKERS' PNEUMOCONIOSIS IN VIETNAM SURFACED COAL MINERS
115INFLUENCE OF ATMOSPHERIC MICROPARTICLES ON MITOCHONDRIAL MEMBRANES IN POPULATION OF URBANIZED TERRITORY
115THE ASSOCIATION OF DUST EXPOSURE WITH RESPIRATORIC SYMPTOMS, LUNG FUNCTION AND CHEST X-RAY IN CERAMIC INDUSTRY WORKERS
116A SRI LANKAN PATIENT WITH COMPLICATED SILICOSIS AND PROGRESSIVE MASSIVE FIBROSIS
117EFFECTS OF PARTICULATE MATTER ON AIRWAY DISEASES WITH ANALYSIS OF DATA FROM THE NATIONAL HEALTH INSURANCE SERVICE IN KOREA
117RELATIONSHIP BETWEEN DUST EXPOSURE WITH SERUM INTERLEUKIN 8 LEVEL AND LUNG FUNCTION IN CERAMIC INDUSTRY WORKERS
118OCCUPATIONAL EXPOSURE TO HAZARDOUS CHEMICALS: ITS EFFECTS ON PULMONARY FUNCTION IN THE KOREAN GENERAL POPULATION
118CLINICAL HARMFUL EFFECT OF PARTICULATE MATTER ON ASTHMA: CROSS-NATIONAL ANALYSIS
118CADMIUM PROMOTES AIRWAY INFLAMMATORY RESPONSES BY FACILITATING INFLAMMASOME ASSEMBLY AND INTERLEUKIN-1β SECRETION THROUGH MITOCHONDRIAL DYSFUNCTION
119THE TREND OF THE RESEARCH ABOUT THE CARBON MONOXIDE POISONING IN NORTH KOREA ANALYZED IN MEDICAL JOURNAL PUBLISHED IN NORTH KOREA
119PREDICTIVE MARKERS FOR EARLY DETECTION OF HAZARDOUS EFFECTS OF NANOMATERIALS
119PROGNOSTIC SIGNIFICANCE OF NOVEL SERUM BIOMARKERS IN SMALL CELL LUNG CANCER: A META-ANALYSIS OF COHORT STUDIES
120OCCUPATIONAL LUNG HEALTH AND PULMONARY FUNCTIONS IN GRANITE PAVING BLOCK MAKERS IN NAWALAPITIYA, RURAL SRI LANKA
121INCREASED SURFACTANT PROTEIN-D SERUM LEVEL, SPUTUM LYMPHOCYTES, AND SPUTUM NEUTROPHILS IN WORKERS AT BIRD MARKET ENVIRONMENT
121LONG-TERM EXPOSURE TO PM 2.5 AND IMAGING PHENOTYPES IN CODA COHORT
121LUNG-SPECIFIC REGULATION OF ANGIOTENSIN SYSTEM BY CHRONIC EXPOSURE OF PARTICULATE MATTER
122THE FACT OF SMOKING AND PASSIVE SMOKING AND SMOKING CESSATION AMONG OUTPATIENTS IN BACH MAI HOSPITAL IN 2018
122KNOWLEDGE, ATTITUDE OF MEDICAL STAFFS BEFORE AND AFTER JOINING THE SMOKING CESSATION TRAINING COURSE ORGANIZED BY THE BACH MAI HOSPITAL IN 2018
122AIR POLLUTION UNDERSTANDING AND EXPOSURE IN A RURAL LOWER SOCIOECONOMIC REGION OF THE PHILIPPINES: A SEMI-QUANTITATIVE SURVEY
123PULMONARY FUNCTION TEST AND PROPORTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AMONG TAXI DRIVERS IN JAKARTA, INDONESIA
123ADDITIONAL DIAGNOSTIC VALUE OF CHEST COMPUTED TOMOGRAPHY IN PATIENTS WITH PNEUMONIA
123IDENTIFYING ACTINOMYCES IN UNCERTAIN PULMONARY LESIONS ON RADIOGRAPHIC IMAGE: A CASE REPORT AND LITERATURE REVIEW
123MASSIVE HAEMOPTYSIS IN PATIENTS WITH MELIOIDOSIS: 2 CASES AND REVIEW OF LITERATURE
124THE USE OF INAPPROPRIATE ANTIBIOTICS IN PATIENTS ADMITTED TO INTENSIVE CARE UNITS WITH NURSING HOME-ACQUIRED PNEUMONIA AT A KOREAN TEACHING HOSPITAL
125ACHROMOBACTER XYLOSOXIDANS BACTEREMIA ACHROMOBACTER XYLOSOXIDANS BACTEREMIA: REPORT OF THREE CASES AND REVIEW OF THE LITERATURE
125BRONCHIAL ATRESIA WITH INFECTION: A SURGICAL CASE REPORT
125ARE STEROIDS REALLY INEFFECTIVE FOR INFLUENZA PNEUMONIA?
125EFFECT OF NLRP3 INFLAMMASOME IN PNEUMONIA CAUSED BY INFLUENZA A VIRUS H1N1 AND MRSA
126EVALUATION OF LUNG EXPANSION AFTER SINGLE-TROCAR VIDEO-ASSISTED FLEXIBLE THORACOSCOPIC DEBRIDEMENT UNDER LOCAL ANESTHESIA FOR MULTILOCULATED PARAPNEUMONIC EMPYEMA
126THE INCIDENCE OF HERPESVIRAL AND RESPIRATORY VIRAL INFECTION IN CHRONIC SIMPLE BRONCHITIS IN REMISSION IN PREGNANT WOMEN
126ENDOTHELIN-1 CONTENT IN PREGNANT WOMEN WITH CHRONIC SIMPLE BRONCHITIS ASSOCIATED WITH CYTOMEGALOVIRUS INFECTION
127EFFECT OF NLRP3 INFLAMMASOME IN MRSA INFECTION SECONDARY TO INFLUENZA A VIRUS H1N1 IN VITRO
127SEVERE ADVERSE EVENT RATES AND TREATMENT OUTCOMES BETWEEN CLARITHROMYCIN- AND AZITHROMYCIN-CONTAINING REGIMENS IN MAC LUNG DISEASE: A PROPENSITY SCORE ANALYSIS
128PULMONARY CRYPTOCOCCOSIS PRESENTING AS A LARGE CAVITARY LUNG MASS IN AN IMMUNOCOMPETENT ADULT
129IMPROVEMENT OF LUNG ASPERGILLOSIS RISK THROUGH EXAMINATION OF HUMAN ASPERGILLUS GALACTOMANNAN FROM BRONCHOALVEOLAR LAVAGE IN PATIENTS SUSPECT LUNG CANCER
129A COMPARISON OF A FLUOROQUINOLONE-CONTAINING REGIMEN AND STANDARD REGIMEN IN TREATMENTS FOR PULMONARY MYCOBACTERIUM AVIUM COMPLEX DISEASE
129ANALYSIS ON EFFECTIVE TREATMENT FOR CLARITHROMYCIN-RESISTANT MYCOBACTERIUM AVIUM COMPLEX LUNG DISEASE
130LOW REPRODUCIBILITY OF THE SERUM GALACTOMANNAN ANTIGEN ASSAY IN PATIENTS WITH DEFINITE AND SUSPECTED INVASIVE PULMONARY ASPERGILLOSIS
130ULTILITY OF CRYPTOCOCCUS ANTIGEN DETECTION IN BRONCHOALVEOLAR LAVAGE FLUID IN DIAGNOSIS OF CRYPTOCOCCUS PNEUMONIA
130CLINICAL CHARACTERISTICS OF CRYPTOCOCCAL INFECTIONS IN A GENERAL HOSPITAL
131THE CORRELATION OF QUICK SOFA SCORE WITH SERUM LACTATE LEVEL IN HOSPITALIZED PNEUMONIA PATIENT WITH SEPSIS IN ARIFIN ACHMAD GENERAL HOSPITAL OF RIAU PROVINCE
131GALACTOMANNAN TEST IN BRONCHIAL WASHING FLUID IS USEFUL FOR DIAGNOSIS OF CHRONIC NECROTIZING PULMONARY ASPERGILLOSIS IN IMMUNE NORMAL PATIENTS
131THE EVIL UNLEASHED FROM PANDORA'S BOX: PANDORAEA APISTA COLONIZATION IN A PATIENT WITH LUNG ADENOCARCINOMA
132BACTERIAL PATTERN AND DRUGS-SENSITIVITY TEST ON PATIENTS WITH PIOPNEUMOTHORAX AT H. ADAM MALIK GENERAL HOSPITAL, MEDAN
132BACTERIAL ETIOLOGY AND ANTIBIOTIC SUSCEPTIBILITY PATTERN IN VENTILATOR-ASSOCIATED PNEUMONIA AT INTENSIVE CARE UNIT, CA MAU GENERAL HOSPITAL.
132CAVITARY PNEUMONIA IN AN OTHERWISE IMMUNOCOMPETENT HOST [WHO UNDERWENT NUTRITIONAL CHANGES]: A CASE REPORT
133FACTORS AFFECTING IN-HOSPITAL MORTALITY OF NON-TUBERCULOUS MYCOBACTERIAL PULMONARY DISEASE
133RETROSPECTIVE EXAMINATION OF PNEUMOCYSTIS JIROVECII DNA (PCR) POSITIVE CASES IN OUR HOSPITAL
133COMPARATIVE ANALYSIS OF INVASIVE AND NON-INVASIVE PNEUMOCOCCAL DISEASE CASES IN KOCHI, JAPAN
134DEVELOPMENT OF REAL-TIME PREDICTION MODEL FOR PNEUMONIA BASED ON CLINICAL AND ENVIRONMENTAL DATA USING DEEP LEARNING
134#COUGHDAB INITIATIVE: USE OF SOCIAL MEDIA IN HEALTHCARE ADVOCACY
134BACTERIA ISOLATED FROM THE AIRWAYS IN PATIENTS WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS: ASSOCIATION WITH INHALED CORTICOSTEROIDS
135SUCCESSFUL MANAGEMENT OF PULMONARY ASPERGILLOSIS IN SARDJITO HOSPITAL YOGYAKARTA
135THE CHARACTERISTICS OF PSEUDOMONAS AERUGINOSA HOSPITAL ACQUIRED PNEUMONIA AT BACH MAI HOSPITAL FROM SEPTEMBER 2016 TO AUGUST 2017
135PULMONARY ASPERGILLOMA IN A PATIENT WITH ANOREXIA NERVOSA: A CASE REPORT
136COPEPTIN AND NEUTROPHIL LYMPHOCYTE COUNT RATIO AS A PREDICTOR OF INTENSIVE CARE ADMISION IN COMMUNITY PNEUMONIA IN HOSPITAL DR. MOEWARDI SURAKARTA
136THE CHARACTERISTICS OF MULTI ANTIBIOTIC RESISTANT PNEUMONIA AT BACH MAI HOSPITAL FROM MAY 2018 TO DECEMBER 2018
Tuberculosis
136RISK FACTORS OF LATENT TUBERCULOSIS AMONG HEMODIALYSIS PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE
137TUBERCULOUS PLEURISY MIMICKING MESOTHELIOMA
137FACTORS ASSOCIATED WITH UNUSUAL RADIOLOGICAL IMAGES OF PULMONARY TUBERCULOSIS
137CHARACTERISTICS OF ACTIVE TUBERCULOSIS PATIENTS WHO DOES NOT SHOW POSITIVE ON T-SPOT.TB
137RARE DISEASE :TUBERCULAR MONOARTHRITIS OF WRIST
138YOUNG LADY WITH DISSEMINATED MULTI DRUG RESISTANT(MDR) TUBERCULOSIS INVOLVING LUNG AND BRAIN
139A CURIOUS CASE OF PROGRESSIVE VOCAL FATIGUE AND CHRONIC DRY COUGH
139DELAYED DIAGNOSED PULMONARY TUBERCULOSIS IN PULMONARY EMBOLISM OF ULCERATIVE COLITIS PATIENT
140VALIDATION OF A RISK ASSESSMENT QUESTIONNAIRE FOR CHILDHOOD TUBERCULOSIS
140THE DIFFERENCES BETWEEN MALONDYALDEHID (MDA) OF LUNG TUBERCULOSIS PATIENTS, LUNG TUBERCULOSIS WITH DIABETES MELLITUS TYPE 2 AND HEALTHY PEOPLE IN MEDAN, INDONESIA
141CORRELATION OF BODY MASS INDEX WITH TIME TO SPUTUM CONVERSION AMONG PATIENTS BEING TREATED WITH SHORTER MULTI-DRUG RESISTANT TUBERCULOSIS REGIMEN AT ADAM MALIK HOSPITAL, INDONESIA
142UNUSUAL PARADOXICAL RESPONSE OF TUBERCULOSIS MIMICKING LUNG MALIGNANCY, A CASE OF XDR TUBERCULOSIS
143DIFFERENT EFFECTS OF PREVIOUS TUBERCULOSIS ON SARCOPENIA IN ELDERLY PEOPLE OF Republic of Korea BY GENDER
143SENSITIVITY COMPARISON OF THE NEUTROFIL LIMFOSITE RATIO VALUE OF PLEURA FLUID AND BLOOD SERUM IN PLEURAL EFFUSION PATIENTS AT HAJI ADAM MALIK GENERAL HOSPITAL, MEDAN
143THE COMPARISON OF VITAMIN C LEVEL BETWEEN PULMONARY TUBERCULOSIS WITH DIABETES MELLITUS, PULMONARY TUBERCULOSIS AND CONTROL IN MEDAN
143THE STUDY OF FACTORS OF DELAY OF TUBERCULOUS PATIENTS' DIAGNOSIS AT KOTO HOSPITAL
146THE EFFECT OF CURCUMA ON CHEST X-RAY IMPROVEMENT AND SPUTUM COVERSION IN PATIENTS WITH INTENSIVE PHASE TREATMENT OF PULMONARY TUBERCULOSIS
146THE EFFECT OF CURCUMA ON LIVER FUNCTION TEST AND GASTROINTESTINAL SIDE EFFECT IN PATIENTS WITH INTENSIVE PHASE TREATMENT OF PULMONARY TUBERCULOSIS
146PULMONARY FUNCTION IMPAIRMENT IN PATIENTS WITH TREATED SMEAR POSITIVE PULMONARY TUBERCULOSIS
147EXTRA-PULMONARY PRIMARY MULTI-DRUG RESISTANT TUBERCULOSIS PRESENTING AS CERVICAL LYMPHADENITIS
147ACCIDENTAL INOCULATION OF MYCOBACTERIUM TUBERCULOSIS FOLLOWING NEEDLE PRICK-HAZARD TO HEALTHCARE WORKERS
148CO-EXISTING TUBERCULOSIS AND LYMPHOMA IN A MIDDLE AGED MAN: A PRISONER'S MISERY
149TUBERCULOSIS RISK FACTORS AND MYCOBACTERIUM TUBERCULOSIS TRANSMISSION AMONG HIV-INFECTED PATIENTS IN VIETNAM
149THE GREAT MASQUERADER: A CASE OF TUBERCULOSIS PRESENTING AS MEDIASTINAL MASS AND SADDLE EMBOLUS
149UNDERLYING COMORBIDITIES IN TUBERCULOSIS MENINGITIS: A VIETNAMESE OBSERVATIONAL RETROSPECTIVE STUDY
150DRUG SUSCEPTIBILIY PATTERN OF ENDOBRONCHIAL TUBERCULOSIS
149A RARE AND UNUSUAL PRESENTATION OF A COMMON PULMONARY DISEASE
151SIMULTANEOUS COEXISTANCE OF MALIGNANCY AND TUBERCULOSIS – A SRI LANKAN EXPERIENCE
151PREVALENCE OF POST TUBERCULOSIS-CHRONIC OBSTRUCTIVE PULMONARY DISEASE AT A TERTIARY REFERRAL CENTRE KUALA LUMPUR
152MY CHEESY HEART: A CASE OF TB PERICARDITIS
153CASE STUDY: 79-YEAR-OLD MALE PRESENTS WITH PANCYTOPENIA AND PRODUCTIVE COUGH
153USING SURVIVAL ANALYSIS TO IDENTIFY RISK FACTORS OF ADVERSE EFFECTS ONSET OF KANAMYCIN AMONG MULTIDRUG RESISTANT TUBERCULOSIS PATIENTS IN MOEWARDI HOSPITAL SURAKARTA INDONESIA
153FACTORS ASSOCIATED WITH UNDER-REPORTING OF TUBERCULOSIS CASES IN DR. MOEWARDI HOSPITAL, SURAKARTA, INDONESIA
154THE CORRELATION OF ADVERSE EFFECTS WITH THE EFFICACY, THE CLINICAL SYMPTOMS SEQUELAE AND THE QUALITY OF LIFE IN MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS
154CLINICAL, PARACLINICAL MANIFESTATION AND THE SUPPORTIVE TREATMENT RESULTS OF PLEURAL IRRIGATION WITH NORMAL SALINE IN THE TUBERCULOUS PLEURAL EFFUSIONS
154A CASE REPORT: RAPIDLY PROGRESSIVE PNEUMONIA
154PULMONARY TUBERCULOSIS PRESENTING AS HOARSENESS: A CASE REPORT
155CRANIOCERVICAL JUNCTION TUBERCULOSIS: UNUSUAL SITE OF ANCIENT DISEASES
155A PREGNANT PATIENT WITH NTM INFECTION: A CASE REPORT
155LUNG TUBERCULOSIS MIMICKING MALIGNANCY IN RADIOGRAPHY FINDINGS
156PRIMARY MULTIDRUG RESISTANT TUBERCULOSIS (MDR-TB) AMONG TYPE-2 DIABETES MELLITUS (DM) PATIENT: CASE SERIES
156EVALUATING THE EFFECTIVENESS OF THERAPEUTIC INTERVENTION COUNSELING IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN NGHE AN PROVINCE
156ADHERENCE TO GOLD RECOMMENDATIONS ON MANAGEMENT OF STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN MANILA DOCTORS HOSPITAL OUTPATIENT CLINICS
157OPTIMISE RESOURCES ENABLE BETTER MANAGEMENT OF PATIENTS AFFLICTED WITH CHRONIC OBSTRUCTIVE PULMONARY DISORDER (COPD) IN HOSPITAL
157THE EFFICACY OF EARLY DETECTION BUNDLE OF COPD IN TAIWAN
157EFFECTS OF VITAMIN C ON THE SEVERITY OF CHRONIC OBSTRUCTIVE LUNG DISEASE IN NEVER SMOKERS
158ACUTE EXACERBATION (AE) OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): ASSESSMENT OF SEVERITY
158HOME NON-INVASIVE VENTILATION FOR A PATIENT AFTER ACUTE EXACERBATION OF COPD
158ACUTE EXACERBATION (AE) OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): ASSESSMENT OF SEVERITY
158FIXED AIRWAY OBSTRUCTION (FAO) MAY BE REDEFINE IN COPD ACCORDING TO EXACERBATION
159DOSE-ESCALATION STRATEGY TO INCREASE ADHERENCE TO ROFLUMILAST IN ASIAN PATIENTS WITH COPD
159CORRELATION BETWEEN INSPIRATORY CAPACITY PROFILE AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
159OBSTRUCTION POST BRONCHODILATOR IN PULMONARY FUNCTION TEST: ARE THEY COPD?
160ISOFLAVONE AGLYCONES ATTENUATE CIGARETTE SMOKE-INDUCED EMPHYSEMA VIA SUPPRESSION OF NEUTROPHILIC INFLAMMATION IN A COPD MURINE MODEL
160LNCRNA NEAT1 REGULATES IL-6 AND IL-8 MRNA EXPRESSION IN LUNG EPITHELIAL CELLS STIMULATED BY CIGARETTE SMOKE
160CORRELATION BETWEEN WOOD DUST LEVELS WITH INTERLEUKIN-8 IN BLOOD SERUM AMONG WOOD PROCESSING WORKERS AT X COMPANY, TANJUNG MORAWA-NORTH SUMATERA
161SERUM CC-16 LEVEL BETWEEN BRONCHIECTASIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS
161THE IMPACT OF 1-MONTH AND 2-MONTH UPPER AND LOWER LIMB EXERCISE TO MUSCLE MASS IN COPD PATIENTS
161COMPARISON OF "OPEN TRIPLE" COMBINATIONS OF INHALED LONG-ACTING MUSCARINIC ANTAGONIST, LONG-ACTING Β2-AGONIST AND AN INHALED CORTICOSTEROID IN PATIENTS WITH ASTHMA, COPD AND ASTHMA-COPD OVERLAP
162DIETARY PROTEIN INTAKE AND THE RISK OF EXACERBATION IN MILD TO MODERATE COPD
COPD
162NEUTROPHIL-LYMPHOCYTE RATIO (RNL) AND C-REACTIVE PROTEIN IN COPD PATIENT IN PERSAHABATAN HOSPITAL JAKARTA INDONESIA
162ASSOCIATION BETWEEN PATIENT REPORTED OUTCOME MEASURES AND PHYSICAL ACTIVITY IN OBSTRUCTIVE RESPIRATORY DISEASE
163THE EFFECT OF 1-MONTH AND 2 MONTH UPPER AND LOWER LIMB TRAINING TO MAXIMAL OXYGEN UPTAKE (VO2 MAX) IN COPD PATIENTS
163CLINICAL CHARACTERISTICS OF COPD PATIENTS IN Republic of Korea
163DISTRIBUTION OF COMMON PATHOGENS AND CLINICAL CHARACTERISTICS FOR FUNGAL INFECTION ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
164COMPARISON OF LAMA/LABA AND ICS/LABA AS INITIAL TREATMENT FOR COPD
164CLINICAL CHARACTERISTICS OF COPD PATIENTS SUSPECTED OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION
164RELATIONSHIP BETWEEN NEUTROPHIL SPUTUM AND FEV1 IN CHRONIC OBSTRUCTIVE DISEASE PATIENTS IN SARDJITO HOSPITAL YOGYAKARTA
165THE IMPACT OF LONG-ACTING BETA-2 AGONIST OR LONG-ACTING ANTICHOLINERGIC TO BODE INDEX AND QUALITY OF LIFE IN STABLE COPD PATIENTS GROUP B
165ASSESSING INHALER USE TECHNIQUE IN COPD PATIENTS
165EXPLORING THE HETEROGENEITY OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A LATENT CLASS ANALYSIS
166IMPROVING CARE IN OUR COPD COHORT
166DEVELOPMENT OF AN ACCURATE OPERATIONAL DEFINITION FOR ASTHMA USING DECISION TREE MODEL
167DAILY PHYSICAL ACTIVITY AND QOL IN PATIENTS WITH COPD. DIFFERENCE BETWEEN NON-ACO AND ACO DURING PEDOMETER INTERVENTION
167RISK OF GOUT IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A COMMUNITY BASED STUDY
168DIAGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) USING A SMARTPHONE-BASED COUGH-CENTRED ALGORITHM IN A MIXED DISEASE ACUTE-CARE COHORT
168PREDIFFERENTIATED AMNIOTIC FLUID MESENCHYMAL STEM CELLS ENHANCE REGENERATION OF LUNG TISSUES AND AMELIORATE ELASTASE-INDUCED PULMONARY EMPHYSEMA IN MICE MODEL
169EVALUATION OF PRACTICE PATTERN OF COPD AMONGST PHYSICIANS OF THREE ASIAN COUNTRIES: A SURVEY IN NEPAL, SRI LANKA AND MALAYSIA
169CARIOVASCULAR EFFECTS OF PHARMACOTHERAPHY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS
169EVALUATION OF PRACTICE PATTERN OF COPD AMONGST PULMONOLOGISTS IN ALGERIA
170REGIONAL DISTRIBUTION AND CLINICAL CHARACTERISTICS OF BACTERIAL EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN Republic of Korea
170EFFECT OF UPPER-LIMB ENDURANCE AND STRENGTH TRAINING ON DYSPNEA SCALE, FUNCTIONAL CAPACITY, QUALITY OF LIFE AND PULMONARY FUNCTION TEST IN COPD PATIENTS
171ROLE OF ALLOSTERIC EFFECTS AND KCA CHANNEL ACTIVITY IN SYNERGISTIC ACTION BETWEEN LABAS AND LAMAS
171ASSOCIATION BETWEEN NUTRITIONAL STATUS AND BLOOD GAS ANALYSIS RELATED PARAMETERS IN ELDERLY PATIENTS WITH ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH RESPIRATORY FAILURE
172FACTORS ASSOCIATED WITH SMOKING STATUS IN COPD PATIENTS
172STABLE CLINICAL COURSE OF COPD PATIENTS IN THE ERA OF DUAL BRONCHODILATOR THERAPY: THE REAL-WORLD DATA
172A DIFFERENCE ANALYSIS FOR BLOOD ROUTINE TEST INDEXES OF COPD PATIENTS IN ACUTE EXACERBATION PHASE, RECOVERY PHASE AND STABLE PHASE
173THE ASSOCIATION BETWEEN READMISSION AND DIFFERENT LEVELS OF NEUTROPHIL OR LYMPHOCYTE COUNTS FOR HOSPITALIZED PATIENTS WITH AECOPD
173ABSENCE OF EXHALATION BEFORE INHALER USE IS ASSOCIATED WITH SEVERE ACUTE EXACERBATION IN PATIENTS WITH COPD
173ASSOCIATION OF INHALED CORTICOSTEROID AND THE FREQUENCY OF ACUTE EXACERBATIONS IN PATIENTS WITH SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
174EVALUATION OF A FLYING DISC GAME AS A PHYSICAL ACTIVITY FOR COPD PATIENTS
Lung Cancer
174CLINICAL, PARACLINICAL CHARACTERISTICS AND HISTOPATHOLOGY CLASSIFICATION OF LUNG ADENOCARCINOMA BY IASLC/ATS/ERS 2011
174CORRELATION BETWEEN EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION AND HISTOLOGIC CLASSIFICATION OF LUNG ADENOCARCINOMA ACCORDING TO THE IASLC/ATS/ERS IASLC/ATS/ERS2011
175PROGNOSTIC IMPACT OF THE PRESENCE OF COPD IN PATIENTS WITH NSCLC UNDER CONVENTIONAL SYSTEMIC CHEMOTHERAPY
175A CASE OF LUNG CANCER WITH ALK REARRANGEMENT DIAGNOSED IN ABDOMINAL LYMPH NODE BIOPSY IN THE PATIENT WITH END-STAGE RENAL DISEASE UNDERGOING HAEMODIALYSIS
176PREDICTIVE FACTORS OF OSIMERTINIB AS SALVAGE TREATMENT FOR METASTATIC EGFR T790M POSITIVE LUNG ADENOCARCINOMA
176FACTORS AFFECTING CHRONIC COUGH FOLLOWING LUNG CANCER SURGERY
177RARE CASE OF LUNG ADENOCARCINOMA PRESENTING AS LUNG ABSCESS
177IMMUNE HISTOCHEMISTRY PROFILES AND OTHER CANCER ASSOCIATIONS AMONG LUNG NEOPLASMS DIAGNOSED AT A TERTIARY CARE UNIT IN SRI LANKA
177A CASE OF PULMONARY PLEOMORPHIC CARCINOMA WITH EFFECTIVE RADIOTHERAPY
178BEST TIME OF PLEURODESIS ON PARAMALIGNANT PLEURAL EFFUSION
178A GIANT CELL TUMOR (GCT) OF THE HAND WITH LUNG METASTASES- A CASE REPORT
178ASSOCIATION BETWEEN CLINICOPATHOLOGICAL PARAMETERS AND THE EFFICACY OF IMMUNE CHECKPOINT INHIBITOR THERAPY IN PATIENTS WITH BIOPSY-DIAGNOSED NON-SMALL-CELL LUNG CANCER
179A CASE OF LARGE CELL LUNG CANCER SUCCESSFULLY TREATED WITH PEMBROLIZUMAB, BUT COMPLICATED WITH CHOLANGITIS
179A CASE OF INTRAVENTRICULAR THROMBUS AFTER SIMULTANEOUS SURGERY FOR LEFT LUNG CANCER AND RIGHT BREAST CANCER
179A CASE OF MICRONODULAR THYMOMA WITH LYMPHOID STROMA
180RETROSPECTIVE STUDY OF PNEUMONITIS DEVELOPED AFTER ADMINISTRATION OF DURVALUMAB IN CLINICAL PRACTICE
180ANOMALOUS BRANCH OF POSTERIOR SEGMENTAL VEIN (V2) IN THE RIGHT UPPER LOBE OF THE LUNG
180RAPIDLY GROWING ECTOPIC THYMOMA OF THE MIDDLE MEDIASTINUM
181A CASE OF A BRONCHOGENIC CYST ARISING FROM THE DIAPHRAGM COMPLETELY RESECTED UNDER VIDEO-ASSISTED THORACOSCOPIC SURGERY WITH CO2 INSUFFLATION
181A CASE REPORT: PRIMARY PULMONARY LYMPHOMA DEVELOPING IN POST PULMONARY TUBERCULOSIS CAVITY
182CLINICAL COURSE OF SMALL ENHANCING BRAIN NODULE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
182QUANTIFICATION OF THE INDEPENDENT PROGNOSTIC VALUE OF CHARLSON COMORBIDITY INDEX AMONG PATIENTS WITH NON-SMALL CELL LUNG CANCER
183TRANSFORMATION TO SMALL CELL LUNG CANCER AFTER PLATINUM-BASED DOUBLET THERAPY IN PATIENTS OF LUNG ADENOCARCINOMA WITH WILD TYPE EPIDERMAL GROWTH FACTOR RECEPTOR: A CASE REPORT
184PRETREATMENT DIETARY HABITS WITH HIGH N-3/N-6 POLYUNSATURATED FATTY ACID RATIO AND MILK INTAKE MAY AFFECT THE ADVERSE EVENTS DURING CHEMOTHERAPY IN LUNG CANCER PATIENTS
184CLINICAL MANIFESTATIONS OF ADRENAL INSUFFICIENCY AFTER ANTI-PD-1 ANTIBODY TREATMENT IN NON-SMALL CELL LUNG CANCER
185POSTOPERATIVE NEUTROPHIL-TO-LYMPHOCYTE RATIO AMONG THE CASES WITH NON-SMALL CELL LUNG CANCER
185A CURIOUS CASE OF ATYPICAL PULMONARY LUNG NEUROENDOCRINE TUMOUR WITH LOW MITOTIC ACTIVITY: WHAT'S NEXT?
185PREDICTIVE FACTORS FOR LONG-TERM RESPONDERS IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH TYROSINE KINASE INHIBITOR
186ASSESSMENT OF INTER-TUMOUR HETEROGENEITY AMONG PRIMARY AND METASTATIC LESIONS IN A PATIENT WITH UNTREATED LUNG CANCER BY DNA METHYLATION PROFILING: AN AUTOPSY CASE
186CORRELATION BETWEEN STAGING OF SMALL CELL LUNG CANCER AND INFLAMMATORY MARKER
186TWO CASES OF THE LUNG CANCER IN THE 40-YEAR-OLD GENERATION WHICH ABNORMALITY COULDN'T BE POINTED OUT BY A PET CHECK
187PROPHYLACTIC USE OF GOSHAJINKIGAN (TJ107) FOR PREVENTION OF TAXANE-BASED CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
187FREQUENCY OF ALK REARRANGEMENTS IN NON-SMALL CELL LUNG CANCER PATIENTS IN CHO RAY HOSPITAL
187LYMPHANGITIS CARCINOMATOSIS DUE TO CARDIAC ANGIOSARCOMA- A DILEMMA IN DIAGNOSIS
188SITUS INVERSUS TOTALIS COMPLICATED WITH BRONCHIAL AND LARYNGEAL CARCINOMA - A CASE REPORT
188ENHANCED CERULOPLASMIN MEDIATES TUMOR ANGIOGENESIS IN LUNG CANCER
190ALBUMIN-GLOBULIN RATIO IS A PREDICTIVE BIOMARKER OF ANTITUMOR EFFECT OF ANTI-PD-1 ANTIBODY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
190THE PROGNOSTIC VALUE OF SURGERY AND RADIOTHERAPY SEQUENCES IN STAGE IIIA PATHOLOGIC N2 NON-SMALL-CELL LUNG CANCER PATIENTS: A POPULATION-BASED STUDY
191MUCINOUS ADENOCARSINOMA IN MEDIASTINAL TERATOMA: RARE CASE
191DYNAMIC CRITICAL ENDOTRACHEAL OBSTRUCTION DUE TO METASTATIC ANAPLASTIC THYROID CARCINOMA
192INCIDENCE AND MORTALITY OF LUNG CANCER IN IPF, 2012–2016: A NATIONWIDE POPULATION-BASED STUDY IN KOREA
193TREATMENT FOR EARLY STAGE NON-SMALL CELL LUNG CANCER BY STEREOTACTIC BODY RADIATION THERAPY AND THE ROLE OF PET/CT
193SECONDARY PULMONARY HODGKIN'S LYMPHOMA MIMICKING LUNG ABSCESS: A RARE CASE
195SOCIAL DEMOGRAPHICS AND CLINICAL CHARACTERISTICS OF ADULT ASTHMA ADMISSIONS TO CRITICAL CARE UNIT IN AN URBAN TEACHING HOSPITAL
195STUDY OF LUNG INFLATION IN ASTHMA PATIENTS WITH OSMOTIC AIRWAY HYPERRESPONSIVENESS
195THE LEVEL OF ADIPOKINES IN PATIENTS WITH ASTHMA DEPENDING ON BODY WEIGHT
196APPLICATION OF EXTRAFINE BECLOMETHASONE/FORMOTEROL TO ACHIEVE ASTHMA CONTROL IN PATIENTS WITH COLD AND/OR OSMOTIC AIRWAY HYPERRESPONSIVENESS
196ANALYSIS OF CLINICAL EFFECTS OF MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA: A SINGLE INSTITUTIONAL STUDY
196AUDIT OF HIGH RISKS ASTHMA PATIENTS AT RISK OF FATAL-NEAR FATAL ASTHMA EXACERBATION WHO DEFAULT CLINIC VISITS
196HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ASTHMA WITH FIXED AIRFLOW LIMITATION
197ASSESSMENT OF PULMONARY FUNCTION IN ASTHMA DEPENDING ON THE CONDITION OF THE SMALL AIRWAYS
197RELIEVER THERAPY USING INHALED CORTICOSTEROID AND FORMOTEROL VERSUS SHORT ACTING BETA2 AGONIST IN CHRONIC ASTHMATIC PATIENTS: A META-ANALYSIS
197THE EFFECT OF MEPOLIZUMAB TREATMENT IN PATIENTS WITH SEVERE ASTHMA IN 1 YEAR
198EFFECT OF KLEINHOVIA HOSPITA, CURCUMA XANTHORRIZA, NIGELLA SATIVA OPHIOCEPHALUS STRIATUS AGAINST DEGREES OF ASTHMA CONTROL THROUGH DECREASE IL-13 IN PARTIALLY CONTROLLED ASTHMA PATIENTS
199THE EFFICACY AND SAFETY OF BENRALIZUMAB IN JAPANESE PATIENTS WITH SEVERE ASTHMA: A MULTICENTER STUDY
199ADVERSE EVENTS OF AS-NEEDED INHALED CORTICOSTEROID AND FORMOTEROL VERSUS SHORT ACTING BETA2 AGONISTS IN ASTHMA EXACERBATIONS: A META-ANALYSIS
200BREATHE EASY PROGRAMME
200LOW PREVALENCE OF POSITIVE BRONCHODILATOR RESPONSE (BDR) IN PATIENTS REFERRED FOR BRONCHODILATOR STUDY.
201ASSESSING STRATEGIES AND CONTENTS OF MOBILE APPS FOR ASTHMA SELF-MANAGEMENT IN 2019
201EFFICACY AND SAFETY OF AS-NEEDED CORTICOSTEROID PLUS FORMOTEROL MONOTHERAPY IN ADOLESCENTS AND ADULTS WITH MILD AND INTERMITTENT ASTHMA: META ANALYSIS OF RANDOMISED CONTROLLED TRIALS
201THE PATIENT WITH HISTORY OF INHALATION BURN INJURY WHO WERE TREATED WITH ASTHMA IMPROVED SYMPTOMS OF RESPIRATORY DISTRESS AFTER LASER CORDOTOMY
202ANALYSIS OF T CELL-INDUCED BRONCHOCONSTRICTION in vivo AND IN VITRO
202META-ANALYSIS OF REAL-LIFE STUDIES COMPARING INHALED CORTICOSTEROIDS WITH FORMOTEROL VERSUS OTHER RELIEVER THERAPIES FOR ASTHMA CONTROL
203FOREIGN BODY OF THE AIRWAY TRIGGERING SEVERE ASTHMA EXACERBATION
203PREVALENCE AND SEVERITY OF ASTHMA USING WRITTEN AND VIDEO QUESTIONNAIRES OF THE INTERNATIONAL STUDY OF ASTHMA AND ALLERGIES IN CHILDHOOD (ISAAC) IN SRI LANKAN CHILDREN
203ROLE OF SERUM PERIOSTIN AS A BIOMARKER IN DIAGNOSIS OF BRONCHIAL ASTHMA
204POOR ASTHMA CONTROL AND OBESITY DOES THE ASSOCIATION EXIST IN A SRI LANKAN STUDY
Respiratory Neurobiology and Sleep
204FACTORS AFFECTING LUNG TO FINGER CIRCULATION TIME MEASUREMENT FROM POLYSOMNOGRAPHY IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA IN SARAWAK GENERAL HOSPITAL, MALAYSIA
204INHIBITION OF LONG NONCODING MEG3 RESCUES CARDIOMYOCYTE APOPTOSIS INDUCED BY INTERMITTENT HYPOXIA
205THE ROLE OF INTERMITTENT HYPOXIA AS A NEGATIVE REGULATOR OF CD4+CD25+FOXP3+ REGULATORY T CELL DIFFERENTIATION IN ANIMAL MODEL OF OBSTRUCTIVE SLEEP APNOEA
205INFLUENCE OF OBSTRUCTIVE SLEEP APNOEA ON TIMING OF ACUTE CORONARY SYNDROME ONSET
205POLYSOMNOGRAPHY CHARACTERISTICS AND TIMING OF ACUTE CORONARY SYNDROME ONSET IN OBSTRUCTIVE SLEEP APNOEA PATIENTS
206THE OUTCOME OF NASAL STENT VERSUS CONTINUOUS POSITIVE AIRWAY PRESSURE IN THE TREATMENT OF PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA
206SHORT-TERM ADHERENCE WITH POSITIVE AIRWAY PRESSURE THERAPY IN SINGAPORE: AN ANALYSIS USING REAL-WORLD DATA
206A RARE CASE OF SEVERE OBSTRUCTIVE SLEEP APNEA WITH NOCTURNAL HYPOVENTILATION SECONDARY TO CONGENITAL MYOPATHY IN AN ADOLESCENT CHILD
207PSG ANALYSIS OF SEVERE OSA PATIENTS WITH DIFFERENT PERCENTAGE OF CUMULATIVE TIME WITH OXYGEN SATURATION BELOW 90% IN TOTAL SLEEP TIME (T90%)
207CIRCULATING EXOSOMES IN OBSTRUCTIVE SLEEP APNEA INCREASED THE GROWTH AND THE PROLIFERATION OF LUNG CANCER CELLS THROUGH ACTIVATION OF ERK/C-MYC AXIS AND DECREASED CYTOTOXICITY OF CISPLATIN
207COMPARISON OF THE VIETNAMESE VERSION OF FOSQ-10 WITH ESS, PSQI AND AHI IN OSA VIETNAMESE PATIENTS
207EFFECT OF CXCR1-MEDIATED CIH ON MTOR EXPRESSION IN THP-1 CELLS
208EFFECT OF CHRONIC INTERMITTENT HYPOXIA ON GENE EXPRESSION PROFILES OF RAT LIVER: A BETTER UNDERSTANDING OF OSA-RELATED LIVER DISEASE
209CASE REPORT: OBSTRUCTIVE SLEEP APNEA WITH OBESITY HYPOVENTILATION SYNDROME
209CLINICAL CHARACTERISTICS AND OF POLYSOMNOGRAPHY OF THE OBSTRUCT SLEEP APNOEA PATIENTS
209LONG NONCODING RNA LOC103694061 MEDIATES INTERMITTENT HYPOXIA-INDUCED CARDIOMYOCYTE INJURY BY TARGETING MIR-29A-3P
209IMPACT OF AGING ON SLEEP DISORDERED BREATHING
210BILATERAL PNEUMOTHORAX AND ACUTE RESPIRATORY FAILURE IN AN ADULT DIAGNOSED WITH PCP
210SUGGESTIVE ROLE OF LUNG INVOLVEMENT IN SEVERE DENGUE
210EMERGENCE OF RALSTONIA PICKETTI IN CRITICALLY ILL PATIENTS - INNOCENT BYSTANDER OR POTENTIAL THREAT?
211USE OF HIGH FLOW NASAL CANNULA (HFNC) IN SMOKE INHALATION INJURY
211PERFORMANCE OF A MODIFIED CRB-65 SCORE AS A RAPID SCREENING TOOL FOR SEPSIS IN INITIAL EMERGENCY DEPARTMENT: A PROPENSITY SCORE MATCHING STUDY
211PROGNOSTIC FACTORS OF ARDS IN DERMATOMYOSITIS AND POLYMYOSITIS PATIENT ASSOCIATED ILD
212AGE BASED ANALYSIS OF PATIENTS WITH ACUTE RESPIRATORY FAILURE IN ICU
212PROGNOSIS OF FAILED EXTUBATION AFTER BRAIN SURGERY
212THE EFFICACY OF NATIONAL EARLY WARNING SIGN SCORE USED BY RAPID RESPONSE SYSTEM TO REDUCE SUDDEN CARDIAC ARREST
213A CASE OF POSTOPERATIVE ATELECTASIS TREATED BY PRONE POSITIONING IN THE IMMEDIATE POSTOPERATIVE PERIOD OF LUNG TRANSPLANTATION
213NONINVASIVE VERSUS INVASIVE MICROBIAL INVESTIGATION IN CRITICAL ILL PATIENTS WITH PNEUMONIA
213NEUROGENIC PULMONARY EDEMA MASQUERADING AS DIFFUSE ALVEOLAR HEMORRHAGE
214ALBUMIN CHANGES DURING MECHANICAL VENTILATION PREDICT OUTCOMES IN INTENSIVE CARE UNIT PATIENTS
214PEMBROLIZUMAB-RELATED FOATAL MYOCARDITIS - A CASE REPORT
214TRANSLATION AND VALIDATION OF THE KOREAN VERSION OF THE 4 AT FOR DETECTING DELIRIUM IN CRITICALLY-ILL PATIENTS
215EOSINOPHILS COUNT AS A PROGNOSTIC MARKER IN ACUTE RESPIRATORY DISTRESS SYNDROME
215RIBOSOME PROFILING SEQUENCING BASED GENE EXPRESSION DURING LUNG INJURY AFTER ONE-LUNG VENTIALTION
215THE PROGNOSTIC VALUE OF RED CELL DISTRIBUTION WIDTH (RDW) IN SEPSIS AND RELATED-MORTALITY
216MACROLIDES AS ADJUNCTIVE TREATMENT IN SEPSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
216"SUBCLINICAL" BUT "MASSIVE" HAEMOPTYSIS
216OUTCOME OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) ADMITTED TO INTENSIVE CARE UNIT (ICU)
217"ACCURACY OF RISK CALCULATOR PREDICTING POSTOPERATIVE RESPIRATORY FAILURE AND PROLONGED MECHANICAL VENTILATION AFTER A CARDIOTHORACIC SURGERY IN PHILIPPINE HEART CENTER"
217THE VALUE OF BLOOD BNP VARIATIONS DURING MECHANICAL VENTILATOR WEANING IN IMPAIRED CARDIAC CONTRACTILITY PATIENTS WITH ACUTE RESPIRATORY FAILURE
217THE EFFECTIVENESS OF NEBULIZED HEPARIN IN DECREASING DAYS OF MECHANICAL VENTILATION: A META-ANALYSIS AND SYSTEMATIC REVIEW
218MANAGEMENT OF MASSIVE SUBCUTANEOUS EMPHYSEMA USING NEGATIVE PRESSURE WOUND THERAPY DRESSINGS
218A CASE OF HEMOPTYSIS DUE TO BRONCHIAL VARICES TREATED WITH VARICEAL SCLEROTHERAPY
219PREDICTIVE DIAGNOSTIC YIELD OF FLEXIBLE BRONCHOSCOPY FOR CENTRAL LESIONS
219BRONCHOSCOPIC CRYOTHERAPY AS A BRIDGING THERAPY IN THE MANAGEMENT OF ENDOBRONCHIAL MUCOEPIDERMOID CARCINOMA
220CRYOABLATION OF A RARE ENDOBRONCHIAL LESION: NON RESOLVING COUGH IN A YOUNG HEALTHY ADULT MALE PATIENT
220RISK FACTORS FOR PREDICTING THE HYPOXIA IN PATIENTS WITH SEDATION DURING BRONCHOSCOPY
220CHARACTERISTICS OF PLEURISY WITH END-STAGE RENAL DISEASE; FINDINGS WITH THORACOSCOPY UNDER LOCAL ANAESTHESIA
221ENDOBRONCHIAL HAMARTOMA A CASE REPORT
221TREATMENT OF PULMONARY GIANT BULLA BY BRONCHOSCOPY USING ONE–WAY ENDOBRONCHIAL VALVE. A CASE REPORT
221WHOLE LUNG LAVAGE IS SAFE AND EFFECTIVE FOR PULMONARY ALVEOLAR PROTEINOSIS: A TEN YEAR SINGLE CENTRE EXPERIENCE IN HONG KONG
222EFFICACY OF CT-GUIDED DRAINAGE FOR TRAUMATIC HEMOPNEUMOTHORAX
223CASE REPORT ON THE USE OF CRYOTHERAPY IN A 59-YEAR OLD MALE WITH POST INTUBATION TRACHEAL STENOSIS
223THE SAFETY OF TRANSBRONCHIAL LUNG CRYOBIOPSY WITH COMBINATION OF RADIAL ENDOBRONCHIAL ULTRASONOGRAPHY AND FLUOROSCOPIC GUIDANCE IN DIAGNOSIS OF DIFFUSE PARENCHYMAL LUNG DISEASE IN JAPAN
223EFFICACY AND SAFETY OF TALC PLEURODESIS: A SINGLE TERTIARY CENTRE 5 YEAR CASE SERIES
224USEFULNESS OF ELASTOGRAPHY STRAIN RATIO FOR THE EVALUATION OF BENIGN AND MALIGNANT LESIONS DURING ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION
224STENTING FOR TREATMENT BRONCHIAL STENOSIS POST-INTUBATED IN PATIENT WITH SEVERE HYPER-PULMONARY PRESSURE: CASE REPORT
224INTRATHORACIC FINDINGS OF IGG4-RELATED DISEASE ON THORACOSCOPY UNDER LOCAL ANESTHESIA
225EFFICACY OF RAPID PLEURODESIS IN MALIGNANT PLEURAL EFFUSIONS: A META-ANALYSIS
225A CASE OF BRONCHOPULMONARY CARCINOID ARISED IN BRONCHUS DIAGNOSED BY 3 TIMES BRONCHOSCOPY WITH REMOVING NECROTIC TISSUE
225CLINICAL IMPLICATIONS OF INDOCYANINE GREEN FLUORESCENCE-BASED EVALUATION OF PEDUNCULATED PERICARDIAL FAT PAD VASCULARIZATION DURING LUNG CANCER SURGERY: A PILOT ANALYSIS
226ENDOBRONCHIAL ULTRASOUND (EBUS) SONOGRAPHIC FEATURES OF MEDIASTINAL LYMPH NODES ASSOCIATED WITH MALIGNANCY AMONG PATIENTS WHO UNDERWENT EBUS-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (TBNA) BIOPSY
226CRYOSPRAY CAN FREEZE EPITHELIAL CELLS TO DEATH WITH NO FIBROBLAST SCAR
227PHYLLODES TUMOUR: A RARE CAUSE OF ENDOBRONCHIAL METASTASIS
227BALLOON DILATATION IN POST TUBERCULOSIS BRONCHIAL STENOSIS
228EFFECTS OF DEEP MEDITATION MUSIC AND PRANAYAMA DURING BRONCHOSCOPY
229A RETROSPECTIVE COHORT STUDY ON THE EFFECTIVENESS OF INTRAPLEURAL FIBRINOLYTIC THERAPY IN MANAGEMENT OF LOCULATED PLEURAL EFFUSION
229A RARE ENDOBRONCHIAL SOLITARY FIBROUS TUMOR: CASE REPORT
230CRYOTHERAPY RECANALIZATION OF PRIMARY TRACHEAL SQUAMOUS CELL CARCINOMA
231USE OF BRONCHOSCOPIC EXAMINATION OF THE LARYNX PRIOR TO EXTUBATION IN PATIENTS WITH FAILED CUFF LEAK TEST
231SUCCESSFUL PALLIATIVE CRYOABLATION AND RECANALIZATION OF INVASIVE FOLLICULAR THYROID CARCINOMA ENCROACHING INTO THE TRACHEA
232THE RESULTS OF MEDICAL THORACOSCOPY IN DIAGNOSING THE CAUSE OF EXUDATIVE PLEURAL EFFUSION AT THE RESPIRATORY CENTER OF BACH MAI HOSPITAL
232A RARE CASE OF INTRALOBAR PULMONARY SEQUESTRATION COMPLICATED BY SPONTANEOUS HEMOTHORAX IN A 15-YEAR-OLD MALE WHO PRESENTED WITH RECURRENT ABDOMINAL PAIN
232CHILDHOOD SARCOIDOSIS: A CASE REPORT
Paediatric Lung Disease
233ANTENATALLY DIAGNOSED CONGENITAL PULMONARY AIRWAY MALFORMATION: A CASE REPORT
233ASSOCIATIONS OF PERIPHERAL MUSCLE STRENGTH, PULMONARY FUNCTION AND FUNCTIONAL CAPACITY IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS
233THE RELATIONSHIP BETWEEN FATIGUE AND PULMONARY FUNCTIONS IN CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS
234ACQUIRED TRACHEO-OESOPHAGEAL FISTULA IN CHILDREN: A RARE CASE REPORT AND LITERATURE REVIEW
234SERUM 25-(OH) D AND TGF-&BETA 1 LEVELS AND CLINICAL SIGNIFICANCE IN CHILDREN WITH MYCOPLASMA PNEUMONIAE PNEUMONIA COMPLICATED BY WHEEZING
234CONSTRUCTION OF KNOWLEDGE MAP OF CHILDHOOD BRONCHIAL ASTHMA
234A CASE OF JUVENILE DERMATOMYOSITIS MANIFESTING RECURRENT AND PERSISTENT COUGH
235ASSOCIATION BETWEEN SERUM FERRITIN AND PULMONARY FUNCTION IN MALE TOBACCO EXPOSED POPULATION: KOREA NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 2010 TO 2012
235MEASUREMENT AND ANALYSIS OF THE TRACHEOBRONCHIAL TREE OF VIETNAMESE ADULTS BY MULTISLICE COMPUTED TOMOGRAPHY 640
235NONINVASIVE HAEMOGLOBIN BY PULSE CO-OXIMETRY IN THE INTERPRETATION OF SINGLE-BREATH CARBON MONOXIDE DIFFUSION CAPACITY
Respiratory Structure and Function
236IS TEST REPETITION NECESSARY FOR THE 6-MINUTE-WALK TEST (6MWT) USING A 15-METRE COURSE?
236A PILOT ANALYSIS ASSESSING THE POSTOPERATIVE DAILY TREND OF CARBON MONOXIDE DIFFUSING CAPACITY IN LUNG CANCER PATIENTS
237DIFFERENT RESPONSE TO INSPIRATORY RESISTIVE BREATHING IN PATIENTS WITH ASTHMA, COPD AND CHRONIC BRONCHITIS
237JAPANESE CASES OF PRIMARY CILIARY DYSKINESIA WITH DNAH5 AND DNAH11 MUTATIONS
237FEASIBILITY OF SPIROMETRY IN A COHORT OF ELDERS FROM RESIDENTIAL CARE FACILITIES IN THE COLOMBO DISTRICT OF SRI LANKA
238RESPIRATORY AND CIRCULATORY RESPONSES IN LATE-STAGE ELDERLY PEOPLE DURING POSTURAL CHANGES AND WALKING
238THE VALUE OF D-DIMER TEST AND COMBINATION WITH WELLS SCORE, REVISED GENEVA SCORE IN DIAGNOSIS THE PULMONARY EMBOLISM IN PATIENTS WITH COPD EXACERBATIONS
238PREVALENCE AND RISK FACTORS OF PULMONARY EMBOLISM IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATIONS
Pulmonary Circulation
239INTERIM REPORT: LONG-TERM INFLUENCE OF BOSENTAN ON PROGNOSIS, ACTIVITIES OF DAILY LIVING (ADL), CARDIAC FUNCTION AND PULMONARY FUNCTION IN PATIENTS WITH PULMONARY HYPERTENSION SECONDARY TO COPD
239PULMONARY ARTERIAL HYPERTENSION AS THE FIRST PRESENTATION IN ANA-NEGATIVE SLE
239A RARE CAUSE OF HAEMOPTYSIS IN A YOUNG LADY CAUSED BY SYSTEMIC ARTERIALIZATION OF THE LUNG WITHOUT SEQUESTRATION
240EMBOLIC BURDEN SCORE AND RISK OF DEATH IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
240A CASE OF PULMONARY ARTERIOVENOUS FISTULA WITHOUT HEREDITARY HEMORRHAGIC TELANGIECTASIA IN A YOUNG MALE WITH SECONDARY ERYTHROCYTOSIS
240CLINICAL CHARACTERISTICS OF BORDERLINE PULMONARY HYPERTENSION -RETROSPECTIVE SINGLE CENTER ANALYSIS-
240A CASE OF RECURRENT PULMONARY THROMBOEMBOLISM ASSOCIATED WITH METHYLENETETRAHYDROFOLATE REDUCTASE C677T POLYMORPHISM WITH NORMAL RANGE OF PLASMA HOMOCYSTEINE LEVEL
241A RARE CASE OF PULMONARY HEMANGIOMA
241A RARE CASE OF CONGENITAL ABSENCE OF LEFT PULMONARY ARTERY PRESENTING IN LATE ADULTHOOD
242A CASE REPORT OF PULMONARY LANGERHANS CELL HISTIOCYTOSIS
242CLINICAL FEATURES OF SECONDARY PNEUMOTHORAX IN INTERSTITIAL LUNG DISEASE
242PATTERN OF AUTOANTIBODIES INVOLVEMENT IN CONNECTIVE TISSUE DISORDER ASSOCIATED INTERSTITIAL LUNG DISEASES
Other
243CLINICALLY AMYOPATHIC DERMATOMYOSITIS (CADM) WITH RAPID PROGRESSIVE INTERSTITIAL LUNG DISEASE (RP-ILD) RELATED TO ANTI-MDA5 ANTIBODY POSITIVE PRECEDED BY ACUTE HEPATITIS AND CUTANEOUS MANIFESTATIONS
243DIFFUSE CYSTIC LUNG DISEASES: SIMILARITIES AND DIFFERENCES
243NOVEL PRESENTATION OF A KNOWN ENTITY- ORGANIZING PNEUMONIA DUE TO MELIOIDOSIS
244A YOUNG LADY WITH SECONDARY PNEUMOTHORAX DUE TO PULMONARY LYMPHANGIOLEIOMYOMATOSIS- A HOUSE WIFE'S AGONY
245CLINICAL COURSE OF PATIENTS WITH ANTI-SYNTHETASE SYNDROME WITH INTERSTITIAL PNEUMONIA UNDERGOING LONG TERM OXYGEN THERAPY
245DOSE SERUM VEGF-D LEVEL INCREASE WITH CLINICAL COURSE IN THE PATIENTS WITH LYMPHANGIOLEIOMYOMATOSIS?
246LYMPHANGIOLEIOMYOMATOSIS: A CASE REPORT
246COMPREHENSIVE ANALYSIS OF CYTOKINES IN BRONCHOALVEOLAR LAVAGE FLUID OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS: A CROSS-SECTIONAL STUDY
246PREDICTIVE FACTORS OF LONG-TERM USE OF PIRFENIDONE IN PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE
247Ä CASE OF HERMANSKY-PUDLAK SYNDROME (HPS) WITH MPO-ANCA POSITIVE ENTEROCOLITIS
247OCCURRENCE OF PNEUMOTHORAX IN PATIENTS UNDER TREATMENT WITH NINTEDANIB
247COMPARISON OF DESQUAMATIVE INTERSTITIAL PNEUMONIA WITH OR WITHOUT AUTOIMMUNE FEATURES
248EFFECT OF COMBINATION THERAPY FOR ACUTE RESPIRATORY DISTRESS SYNDROME THROUGH INHIBITING INFLAMMATION AND FIBROSIS IN HUMAN LUNG EPITHELIAL A549 CELLS
248CLINICAL OUTCOMES IN PATIENTS WITH SURGICALLY TREATED PNEUMOTHORAX ASSOCIATED WITH INTERSTITIAL PNEUMONIA: A RETROSPECTIVE ANALYSIS
248PRE-EXISTING INTERSTITIAL LUNG ABNORMALITIES ARE RISK FACTORS FOR IMMUNE CHECKPOINT INHIBITOR-INDUCED INTERSTITIAL LUNG DISEASE IN NON-SMALL CELL LUNG CANCER
249TERT MUTATION ASSOCIATED LUNG FIBROSIS: THE MALAYSIAN REPORTED MYTH
249UPREGULATION OF RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTOR 2 LEVELS IN IDIOPATHIC PULMONARY FIBROSIS
249THE INCIDENCE AND RISK FACTORS FOR ACUTE EXACERBATION OF INTERSTITIAL LUNG DISEASE AFTER NON-PULMONARY SURGERY
250THE USEFULNESS OF DIRECT HEMOPERFUSION USING POLYMYXIN B-DIRECT HEMOPERFUSION(PMX-DHP) IN PATIENTS WITH AE OF ILD
250A RARE CASE OF PLEUROPARENCHYMAL FIBROELASTOSIS (PPFE) CO-EXISTING WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) TREATED WITH NINTEDANIB
250A CASE OF LYMPHANGIOLEIOMYOMATOSIS WHO DEVELOPED REFRACTORY ASCITES WITH FEW LUNG LESIONS
251THE ANTIFIBROTIC AGENTS TREATMENT IN THE IDIOPATHIC PULMONARY FIBROSIS PATIENTS OF TAIWAN- THE REAL-WORLD EXPERIENCE FROM CHENG-HSIN GENERAL HOSPITAL
251THE FIRST EXPERIENCE OF DIAGNOSING IDIOPATHIC PULMONARY OSSIFICATION BY TRANSBRONCHIAL LUNG BIOPSY
251COMPARISON OF AUTOANTIBODY POSITIVE RATE BETWEEN PATIENTS DEVELOPED AND NOT DEVELOPED AAV IN ANCA POSITIVE INTERSTITIAL LUNG DISEASE
253THE EFFECTIVENESS AND SAFETY OF ANTIFIBROTICS FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS: A RETROSPECTIVE SINGLE CENTER ANALYSIS
253A CASE OF SUMMER-TYPE HYPERSENSITIVITY PNEUMONITIS WITH SEVERE OBSTRUCTIVE IMPAIRMENT CAUSED BY MEMBRANOUS BRONCHIOLITIS
254A CASE WITH SUBACUTE INTERSTITIAL LUNG DISEASE
254COMPARISON OF CLINICO-RADIOGRAPHIC FEATURES BETWEEN ANTHRACOFIBROSIS AND LUNG CANCER
254A CASE OF A RAPIDLY GROWING INTRATHORACIC CHEST WALL TYPE LIPOMA: RESECTED BY VIDEO-ASSISTED THORACOSCOPIC SURGERY
255SOCIO-ECONOMIC DETERMINANTS OF RESOURCE PROVISION OF PULMONOLOGY IN RUSSIA
255NATURAL COURSE OF UNTREATED NONTUBERCULOUS MYCOBACTERIAL PULMONARY DISEASE ACCORDING TO MICROBIOLOGIC DIAGNOSTIC METHOD
255IMPROVEMENT IN OBSTRUCTIVE SLEEP APNEA IN SUPER MORBIDLY OBESE PATIENTS AFTER BARIATRIC SURGERY
256A RARE CASE: POSTERIOR MEDIASTINAL CASTLEMAN'S DISEASE TYPE UNICENTRIC
256PREDICTION OF FEV1 AND DLCO IN LUNG CANCER PATIENTS UNDERGOING LOBECTOMY: COMPARISON BETWEEN ANATOMY, SCINTIGRAPHY, AND QUANTITATIVE COMPUTED TOMOGRAPHY
256HOSPITALIZED PULMONARY REHABILITATIONS AFTER TREATMENT TO IMPROVE ADL
257EFFECT OF IN-PATIENT PULMONARY REHABILITATION FOR POTENTIAL LUNG TRANSPLANT RECIPIENTS WITH DEBILITATED ADVANCED LUNG DISEASES
257COMPARISON OF CHEST DRAINAGE TUBE TYPES (BLAKE VS. THORACIC CATHETER) AFTER LUNG RESECTION
258PULMONARY ARTERY SARCOMA WITH ACUTE PROGRESSION DIAGNOSED BY ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION. A CASE REPORT
258CLINICAL UTILITY OF EAR PROBE IN PULSE OXIMETER FOR ESTIMATING THE OXYGEN SATURATION
258IMPROVE THE COMPETENCY OF NURSING STAFF IN CARING PATIENT WITH NON-INVASIVE VENTILATION (NIV) IN GENERAL MEDICAL WARD
259THE SEVERITY OF NON-CYSTIC FIBROSIS BRONCHIECTASIS (NON-CF BE) ASSOCIATED WITH PERIPHERAL BLOOD EOSINOPHILS AND SERUM IGE LEVELS
259ROLE OF NRF2 IN THE ALLERGIC AIRWAY INFLAMMATION DIFFER BETWEEN BALB/C AND C57BL/6 MICE
260CHEMICAL PLEURODESIS WITH IODOPOVIDONE: EXPLORING ITS UTILITY IN THE CONTEXT OF LACK OF THORACOSCOPY
260EFFECT OF EQUAL RATIO VENTILATION ON RESPIRATORY MECHANICS AND OXYGENATION DURING VOLUME CONTROLLED VENTILATION IN PEDIATRIC PATIENTS
260METASTATIC HEMORRHAGIC TUMOR NECROSIS IN THE LUNG FROM A SARCOMATOID RENAL CELL CARCINOMA IN A 32 YEAR OLD MALE: A CASE REPORT
261STUDY ON THE RELATIONSHIP BETWEEN CPAP AND LEPTIN LEVEL USING CLUSTER ANALYSIS
Clinical Respiratory Medicine
262Young Investigators of the ATS
264A MIDDLE AGED LADY WITH RECURRENT PNEUMOTHORAX DUE TO BIRT HOGG DUBE SYNDROME: A CASE REPORT
264A YOUNG WOMAN WITH RHEUMATOID ARTHRITIS AND RECURRENT HEMOPTYSIS: A CASE OF MULTIPLE CAVITARY PULMONARY RHEUMATOID NODULES WITH INTRAVAVITARY MYCETOMA
265DIAPHRAGMATIC FENESTRATIONS CAUSING RECURRENT CATAMENIAL PNEUMOTHORAX
265HIGH FLOW NASAL OXYGEN TREATMENT FOR RESPIRATORY FAILURE IN ADULTS: A CASE SERIES
266AN UNUSUAL MIMIC: A CASE OF AN ADRENAL TUMOUR MIMICKING A PLEURAL EFFUSION
266A RARE CAUSE OF MULTIPLE BILATERAL LUNG NODULES IN A YOUNG LADY—PULMONARY BENIGN METASTASIZING LEIOMYOMA—A CASE REPORT
266SUCCESSFUL MANAGEMENT OF MIXED RESPIRATORY FAILURE WITH NON-INVASIVE MECHANICAL VENTILATION, IN ISCHEMIC STROKE AND SLEEP APNEA PATIENT
Environmental and Occupational Health and Epidemiology
Respiratory Infections (non-tuberculous)
267VENTILATOR-ASSOCIATED PNEUMONIA SECONDARY TO SPHINGOMONAS PAUCIMOBILIS INFECTION IN A SEPTIC SHOCK PATIENT: A CASE REPORT
267CLINICAL, SUBCLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF INVASIVE PULMONARY FUNGAL INJECTION AT RESPIRATORY CENTER- BACH MAI HOSPITAL
Tuberculosis
267CASE REPORT: THE CASE OF SEVERE MULTI-ORGANES TB DIAGNOSIS IS DELAYED
268THE ROLE OF THORACOSCOPIC IN THE TREATMENT OF EARLY SEQUELAE OF TUBERCULOUS PLEURAL EFFUSION IN NATIONAL LUNG DISEASE HOSPITAL: VIETNAM IN 10 YEARS 1/2009-1/2019
268TNFa-308G/A GENE POLYMORPHISM IN SUSCEPTIBILITY TO PULMONARY TUBERCULOSIS AMONG INDONESIAN POPULATION
268CONCOMITANT LEGENDARY FOES OF MANKIND; CO-INFECTION WITH TUBERCULOSIS AND LEPROSY- A CASE REPORT
269SOCIO-DEMOGRAPHIC AND RISK FACTORS FOR THE DEVELOPMENT OF MULTI DRUG RESISTANT TUBERCULOSIS
COPD
270RELATIONSHIP BETWEEN PHYSICAL INACTIVITY AND WHITE MATER MICROSTRUCTURE DISORDER IN COPD
270CHARACTERISATION OF THE FREQUENT EXACERBATOR IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS: A RETROSPECTIVE STUDY CONDUCTED IN SHANGHAI
270PREVALENCE OF PATIENTS WITH OBSTRUCTIVE LUNG DISEASE AMONG PEOPLE WITH RESPIRATORY SYMPTOMS AT DISTRICT HOSPITALS IN VIETNAM
271THE BRIEF ICF CORE SET FOR OBSTRUCTIVE PULMONARY DISEASES: VALIDATION FROM THE PERSPECTIVE OF CHINESE RESPIRATORY PHYSICIANS
271THE IMPACT OF INFLUENZA VACCINATION AMONG COPD PATIENTS IN A TROPICAL COUNTRY
Lung Cancer
271TREATMENT FOR EARLY STAGE NON-SMALL CELL LUNG CANCER BY STEREOTACTIC BODY RADIATION THERAPY AND THE ROLE OF PET/CT
272THE CONCOMITANT GENE ALTERATIONS IMPACT THE THERAPEUTIC EFFICACY OF EGFR-TKIS IN ADVANCED NSCLC PATIENTS WITH EGFR SENSITIVE MUTATION
272METASTASE IN NON-SMALL CELL LUNG CANCER
272COEXISTED STREPTOCOCCUS AND VEILLONELLA DISPAR MICROBIAL MARKERS IN THE UPPER/LOWER BRONCHIAL TREE AND GUT PREDICT TAIWAN LUNG CANCER
273SEVERE-REFRACTORY ASTHMA AND PRACTICAL SKILLS OF PHYSICIANS IN VIETNAM
273STUDY OF THE CORRELATION BETWEEN GENETIC FEATURES OF FCER2 AND CRHR1 IN CHILDREN WITH ASTHMA
273PERIPHERAL BLOOD BASOPHILS PREDICT ASTHMA CONTROL: A ONE-MONTH PROSPECTIVE COHORT STUDY
273CLINICAL AND INFLAMMATORY FEATURES OF EXACERBATIONS-PRONE ASTHMA IN CHINESE POPULATION: A CROSS-SECTIONAL STUDY
274VARIABILITY OF TOTAL IGE CORRELATES WITH THE ANNUAL SEVERE ASTHMA EXACERBATIONS: A PROSPECTIVE COHORT STUDY IN REAL-WORLD SETTING
274REDUCED BRONCHODILATOR REVERSIBILITY CORRELATES WITH SEVERE ASTHMA AND MORE EXACERBATIONS: A PROSPECTIVE 12-MONTH COHORT STUDY IN A REAL-WORLD SETTING
Respiratory Neurobiology and Sleep
276NOCTURNAL HYPOXEMIA AND MEAN HEART RATE PREDICT CARDIOVASCULAR CONSEQUENCES IN OBSTRUCTIVE SLEEP APNEA: A HISTORICAL CLINIC COHORT STUDY
276SHIFT WORK DISORDER AND INSOMNIA SEVERITY OF HEALTH-CARE WORKERS IN A TERTIARY HOSPITAL IN VIETNAM
Critical Care Medicine
276CLINICAL CHARACTERISTICS AND RISK FACTORS RELATING TO MORTALITY ON PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN VIETNAM
277ACUTE HYPOXEMIC RESPIRATORY FAILURE IN A UNIVERSITY STUDENT OF AFRICAN DESCENT FOLLOWING WATER PIPE (SHISHA) SMOKING: A CASE REPORT AND LITERATURE REVIEW
277LEPTOSPIROSIS MIMICKING VASCULITIS - A CASE REPORT
278UTILISING MEDICAL THORACOSCOPY FOR THE DIAGNOSIS OF TUBERCULOUS PLEURAL EFFUSIONS
278CLINICAL SYMPTOMS AND ETIOLOGIES OF PATIENTS WITH BENIGN CENTRAL AIRWAY OBSTRUCTION AT TERTIARY HOSPITAL IN VIETNAM
Paediatric Lung Disease
278BRONCHIAL ATRESIA MASQUERADING AS NON RESOLVING WHEEZE: A CASE REPORT
Respiratory Structure and Function
279TRACHEAL BRONCHUS AND COMBINED MALFORMATION
Interstitial Lung Disease
279EXTENSIVE PNEUMO-MEDIASTINUM AND SURGICAL EMPHYSEMA IN A PATIENT WITH ORGANIZING PNEUMONIA; AN UNUSUAL OCCURRENCE OF A RELATIVELY RARE DISEASE
Other Tobacco Control
280ARE AUSTRALIAN SMOKERS BECOMING MORE HARDCORE (AND DO WE NEED E-CIGARETTES AS A GAME CHANGER?)
281ANXIETY AND DEPRESSION STATUS IN SMOKERS AND EFFECTS OF DEPRESSION AND ANXIETY ON SMOKING CESSATION TREATMENT
282HOW MUCH DOES THE RISK OF CARDIOVASCULAR DISEASE REDUCE IN EMPLOYEES AFTER QUITTING SMOKING?
282CHARACTERISING SMOKING BEHAVIOUR AMONG ADULT PATIENTS PRESENTING TO HEALTH FACILITIES IN FOUR PROVINCES OF VIETNAM
General Respiratory Care
282MEASURING IMPROVEMENT IN RESPIRATORY CARE VIA HEALTHY LUNG PROGRAM STUDY IN VIETNAM
Mediastinal Mass Lesions
283GERM CELL TUMOURS OF THE ANTERIOR MEDIASTINUM: THREE CASES
284Author Index

Index

2024 MayVol. 29 Issue 5
2024 AprVol. 29 Issue 4
2024 MarVol. 29 Issue 3
2023 MarVol. 29 Supplement 1
ANZSRS/TSANZ Annual Scientific Meeting 2024
2024 FebVol. 29 Issue 2
2024 JanVol. 29 Issue 1
2023 DecVol. 28 Issue 12
2023 NovVol. 28 Issue 11
2023 NovVol. 28 Supplement 4
APSR 2023 Congress Abstracts
2023 OctVol. 28 Issue 10
2023 SepVol. 28 Issue 9
2023 AugVol. 28 Issue 8
2023 JulVol. 28 Issue 7
2023 JunVol. 28 Issue 6
2023 MayVol. 28 Issue 5
2023 AprVol. 28 Issue 4
2023 MarVol. 28 Issue 3
2023 MarVol. 28 Supplement 3
Australian Lung Cancer Conference 2023
2023 MarVol. 28 Supplement 2
ANZSRS/TSANZ Annual Scientific Meeting 2023
2023 FebVol. 28 Issue 2
2023 FebVol. 28 Supplement 1
APSR 2022 Congress Abstracts
2023 JanVol. 28 Issue 1
2022 DecVol. 27 Issue 12
2022 NovVol. 27 Issue 11
2022 OctVol. 27 Issue 10
2022 SepWorld Lung Day 2022
2022 SepVol. 27 Issue 9
2022 AugVol. 27 Issue 8
2022 JulVol. 27 Issue 7
2022 JunVol. 27 Issue 6
Special Issue: Occupational Lung Health
2022 MayVol. 27 Issue 5
2022 AprVol. 27 Issue 4
2022 MarVol. 27 Issue 3
2022 MarVol. 27 Issue s1
ANZSRS and TSANZ abstracts
2022 FebVol. 27 Issue 2
2022 JanVol. 27 Issue 1
2021 DecVol. 26 Issue 12
2021 NovVol. 26 Issue 11
2021 NovVol. 26 Supplement 3
APSR Congress Abstracts
2021 OctVol. 26 Issue 10
2021 SepVol. 26 Issue 9
2021 AugVol. 26 Issue 8
2021 JulVol. 26 Issue 7
2021 JunVol. 26 Issue 6
2021 MayVol. 26 Issue 5
2021 AprVol. 26 Issue 4
2021 AprVol. 26 Issue s2
ANZSRS and TSANZ abstracts
2021 MarVol. 26 Issue 3
2021 FebVol. 26 Issue 2
2021 JanVol. 26 Issue s1
Supplement: APSR Assembly Virtual Meetings
2021 JanVol. 26 Issue 1
2020 DecVol. 25 Issue 12
2020 NovVol. 25 Issue 11
2020 NovVol. 25 Issue s2
Essential update in lung cancer medicine
2020 OctVol. 25 Issue 10
2020 SepVol. 25 Issue 9
Special issue: Interventional Pulmonoogy pearls
2020 AugVol. 25 Issue 8
2020 JulVol. 25 Issue 7
2020 JunVol. 25 Issue 6
2020 JunVol. 25 Supplement 1
ANZSRS and TSANZ abstracts
2020 MayVol. 25 Issue 5
2020 AprVol. 25 Issue 4
2020 MarVol. 25 Issue 3
2020 FebVol. 25 Issue 2
2020 JanVol. 25 Issue 1
2019 DecVol. 24 Issue 12
2019 NovVol. 24 Issue 11
2019 NovVol. 24 Supplement 2
APSR Congress Abstracts
2019 OctVol. 24 Issue 10
2019 SepVol. 24 Issue 9
2019 AugVol. 24 Issue 8
2019 JulVol. 24 Issue 7
2019 JunVol. 24 Issue 6
2019 MayVol. 24 Issue 5
2019 AprVol. 24 Issue 4
2019 MarVol. 24 Issue 3
2019 MarVol. 24 Supplement 1
ANZSRS and TSANZ abstracts
2019 FebVol. 24 Issue 2
2019 JanVol. 24 Issue 1
2018 DecVol. 23 Issue 12
2018 NovVol. 23 Supplement 2
APSR Congress Abstracts
2018 NovVol. 23 Issue 11
2018 OctVol. 23 Issue 10
2018 SepVol. 23 Issue 9
2018 AugVol. 23 Issue 8
2018 JulVol. 23 Issue 7
2018 JunVol. 23 Issue 6
2018 MayVol. 23 Issue 5
2018 AprVol. 23 Issue 4
2018 MarVol. 23 Supplement 1
ANZSRS and TSANZ abstracts
2018 MarVol. 23 Issue 3
2018 FebVol. 23 Issue 2
2018 JanVol. 23 Issue 1
2017 NovVol. 22 Supplement 3
APSR Congress Abstracts
2017 NovVol. 22 Issue 8
2017 OctVol. 22 Issue 7
2017 AugVol. 22 Issue 6
2017 JulyVol. 22 Issue 5
2017 MayVol. 22 Issue 4
2017 AprVol. 22 Issue 3
2017 MarVol. 22 Supplement 2
ANZSRS and TSANZ abstracts
2017 MarVol. 22 Supplement 1
Airway Vista abstracts
2017 FebVol. 22 Issue 2
2017 JanVol. 22 Issue 1
2016 NovVol. 21 Supplement 3
APSR Congress Abstracts
2016 NovVol. 21 Issue 8
2016 OctVol. 21 Issue 7
2016 AugVol. 21 Issue 6
2016 JulVol. 21 Issue 5
2016 MayVol. 21 Issue 4
2016 AprVol. 21 Supplement 2
ANZSRS and TSANZ abstracts
2016 AprVol. 21 Issue 3
2016 MarVol. 21 Supplement 1
Airway Vista abstracts
2016 FebVol. 21 Issue 2
2016 JanVol. 21 Issue 1
2015 DecVol. 20 Supplement 3
APSR Congress Abstracts
2015 NovVol. 20 Issue 8
2015 OctVol. 20 Issue 7
2015 AugVol. 20 Issue 6
2015 JulVol. 20 Issue 5
2015 MayVol. 20 Issue 4
2015 AprVol. 20 Issue 3
2015 MarVol. 20 Supplement 2
ANZSRS and TSANZ abstracts
2015 MarVol. 20 Supplement 1
Airway Vista abstracts
2015 FebVol. 20 Issue 2
2015 JanVol. 20 Issue 1
2014 NovVol. 19 Issue 8
2014 NovVol. 19 Supplement 3
APSR Congress Abstracts
2014 OctVol. 19 Issue 7
2014 AugVol. 19 Issue 6
2014 JulVol. 19 Issue 5
2014 MayVol. 19 Issue 4
2014 AprVol. 19 Issue 3
2014 AprVol. 19 Supplement 2
ANZSRS and TSANZ abstracts
2014 MarVol. 19 Supplement 1
Airway Inflammation
2014 FebVol. 19 Issue 2
2014 JanVol. 19 Issue 1
2013 NovVol. 18 Issue 8
2013 OctVol. 18 Supplement 4
APSR Congress Abstracts
2013 NovVol. 18 Supplement 3
Airway Inflammation
2013 OctVol. 18 Issue 7
2013 AugVol. 18 Issue 6
2013 JulVol. 18 Issue 5
2013 MayVol. 18 Issue 4
2013 AprVol. 18 Issue 3
2013 AprVol. 18 Supplement 2
ANZSRS and TSANZ abstracts
2013 AprVol. 18 Supplement 1
Airway Vista abstracts
2013 FebVol. 18 Issue 2
2013 JanVol. 18 Issue 1
2012 DecVol. 17 Supplement 2
APSR Congress Abstracts
2012 NovVol. 17 Issue 8
2012 OctVol. 17 Issue 7
2012 AugVol. 17 Issue 6
2012 JulVol. 17 Issue 5
2012 MayVol. 17 Issue 4
2012 AprVol. 17 Issue 3
2012 AprVol. 17 Supplement 1
ANZSRS and TSANZ abstracts
2012 FebVol. 17 Issue 2
2012 JanVol. 17 Issue 1
2011 NovVol. 16 Issue 8
2011 NovVol. 16 Supplement 2
APSR Congress Abstracts
2011 OctVol. 16 Issue 7
2011 AugVol. 16 Issue 6
2011 JulVol. 16 Issue 5
2011 MayVol. 16 Issue 4
2011 AprVol. 16 Issue 3
2011 AprVol. 16 Supplement 1
ANZSRS and TSANZ abstracts
2011 FebVol. 16 Issue 2
2011 JanVol. 16 Issue 1
2010 NovVol. 15 Supplement 2
APSR Congress Abstracts
2010 NovVol. 15 Issue 8
2010 OctVol. 15 Issue 7
2010 AugVol. 15 Issue 6
2010 JulVol. 15 Issue 5
2010 MayVol. 15 Issue 4
2010 AprVol. 15 Issue 3
2010 MarVol. 15 Supplement 1
ANZSRS and TSANZ abstracts
2010 FebVol. 15 Issue 2
2010 JanVol. 15 Issue 1
2009 NovVol. 14 Issue 8
2009 NovVol. 14 Supplement 3
APSR Congress Abstracts
2009 OctVol. 14 Supplement 2
Guidelines: Hospital-Acquired Pneumonia
2009 SepVol. 14 Issue 7
2009 Vol. 14 Issue 6
2009 JulVol. 14 Issue 5
2009 MayVol. 14 Issue 4
2009 AprVol. 14 Issue 3
2009 AprVol. 14 Supplement 1
ANZSRS and TSANZ abstracts
2009 MarVol. 14 Issue 2
2009 JanVol. 14 Issue 1
2008 NovVol. 13 Issue 7
2008 NovVol. 13 Supplement 5
APSR Congress Abstracts
2008 NovVol. 13 Supplement 4
Lung Disease
2008 SepVol. 13 Issue 6
2008 SepVol. 13 Supplement 3
ESAP: TB
2008 JulVol. 13 Issue 5
2008 JunVol. 13 Issue 4
2008 MayVol. 13 Issue 3
2008 AprVol. 13 Supplement 2
ANZSRS and TSANZ Abstracts
2008 MarVol. 13 Supplement 1
ESAP Abstracts
2008 MarVol. 13 Issue 2
2008 JanVol. 13 Issue 1
2007 NovVol. 12 Supplement 4
APSR Congress Abstracts
2007 NovVol. 12 Supplement 3
Asthma
2007 NovVol. 12 Issue 6
2007 SepVol. 12 Issue 5
2007 JulVol. 12 Issue 4
2007 MayVol. 12 Supplement 2
ESAP Abstracts
2007 MayVol. 12 Issue 3
2007 MarVol. 12 Supplement 1
ANZSRS and TSANZ Abstracts
2007 MarVol. 12 Issue 2
2007 JanVol. 12 Issue 1
2006 NovVol. 11 Supplement 5
APSR Congress Abstracts
2006 NovVol. 11 Issue 6
2006 SepVol. 11 Supplement 4
Guidelines: Cough
2006 SepVol. 11 Supplement 3
Guidelines: Respiratory Infections
2006 SepVol. 11 Issue 5
2006 JulVol. 11 Issue 4
2006 MayVol. 11 Issue 3
2006 MarVol. 11 Supplement 2
ANZSRS and TSANZ abstracts
2006 MarVol. 11 Issue 2
2006 JanVol. 11 Supplement 1
Surfactant Molecular Pathophysiology
2006 JanVol. 11 Issue 1
2005 NovVol. 10 Supplement 3
APSR Congress Abstracts
2005 NovVol. 10 Supplement 2
Respiratory function tests
2005 NovVol. 10 Issue 5
2005 SepVol. 10 Issue 4
2005 JunVol. 10 Issue 3
2005 MarVol. 10 Supplement 1
ANZSRS and TSANZ abstracts
2005 MarVol. 10 Issue 2
2005 JanVol. 10 Issue 1
2004 DecVol. 9 Supplement 3
APSR Congress Abstracts
2004 NovVol. 9 Issue 4
2004 AugVol. 9 Issue 3
2004 JunVol. 9 Issue 2
2004 MarVol. 9 Supplement 2
APSR Congress Abstracts
2004 MarVol. 9 Supplement 1
Guidelines: Hospital-Acquired Pneumonia
2004 MarVol. 9 Issue 1
2003 DecVol. 8 Issue 4
2003 NovVol. 8 Supplement 1
SARS
2003 SepVol. 8 Issue 3
2003 JunVol. 8 Issue 2
2003 AprVol. 8 Supplement 2
APSR Congress Abstracts
2003 MarVol. 8 Issue 1
2002 DecVol. 7 Issue 4
2002 SepVol. 7 Issue 3
2002 JunVol. 7 Issue 2
2002 MarVol. 7 Supplement 1
APSR Congress Abstracts
2002 MarVol. 7 Issue 1
2001 DecVol. 6 Issue 4
2001 SepVol. 6 Issue 3
2001 JunVol. 6 Supplement 2
Chronic Obstructive Lung Diseases
2001 JunVol. 6 Issue 2
2001 MarVol. 6 Issue 1
2000 DecVol. 5 Issue 4
2000 SepVol. 5 Issue 3
2000 JunVol. 5 Issue 2
2000 JunVol. 05 Supplement 2
TSANZ abstracts
2000 AprVol. 05 Supplement 1
TSANZ abstracts
2000 MarVol. 5 Issue 1
1999 DecVol. 4 Issue 4
1999 SepVol. 4 Issue 3
1999 JunVol. 4 Issue 2
1999 AprVol. 04 Supplement 1
TSANZ abstracts
1999 JanVol. 4 Issue 1
1998 DecVol. 3 Issue 4
1998 SepVol. 3 Issue 3
1998 JunVol. 3 Issue 2
1998 MarVol. 3 Issue 1
1997 DecVol. 2 Issue 4
1997 SepVol. 2 Issue 3
1997 JunVol. 2 Issue 2
1997 MarVol. 2 Issue 1
1996 DecVol. 1 Issue 4
1996 SepVol. 1 Issue 3
1996 JunVol. 1 Issue 2
1996 MarVol. 1 Issue 1